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I. INTRODUCTION 
In the foreseeable future, it is likely that the familiar, paper-based 
patient medical files, contained in thick folders and stored on long 
shelves or in filing cabinets, will become a thing of the past. Both the 
federal government and health care advocates are enthusiastically 
promoting the adoption of health information technology (“HIT”) and 
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electronic health records (“EHR”) systems1 as means to transform and 
improve health care in the U.S.2  
An editorial published in The New York Times in August 2007 
noted that the World Health Organization, in 2000, ranked the U.S. 
health care system 37th out of 191 and identified our poor use of in-
formation technology as among the primary reasons for this “dismal” 
ranking.3 The editorial decried the fact that “American primary care 
doctors lag years behind doctors in other advanced nations in adopting 
electronic medical records or prescribing medication electronically.”4 
Indeed, only seventeen percent of physicians in ambulatory care set-
tings5 use EHR systems to any extent, and only eleven percent of hos-
pitals have fully implemented EHR systems.6 
Medical errors have been estimated to result in as many as 98,000 
deaths each year in the U.S. and to cost as much as $29 billion.7 Ap-
propriate use of carefully designed EHR systems could dramatically 
reduce those numbers. These systems can promote efficiency, dimin-
ish costs, save time, and save lives. For example, the Palo Alto Medi-
cal Foundation learned of Merck & Co.’s recall of certain batches of 
hepatitis A vaccine that had lost their potency and was able, using its 
                                                                                                                  
1. An EHR is a record of “electronically maintained information about an individual’s 
lifetime health status and health care, stored such that it can serve . . . multiple legitimate 
users.” BIOMEDICAL INFORMATICS: COMPUTER APPLICATIONS IN HEALTH CARE AND 
BIOMEDICINE 937 (Edward H. Shortliffe & James J. Cimino eds., 3d ed., Springer 2006) 
(1990) [hereinafter BIOMEDICAL INFORMATICS]. EHR systems, as we are using the term, are 
systems that add to EHR databases information management tools including clinical alerts, 
reminders, decision aids, links to medical literature, and tools for data analysis, such as 
search engines. See id. 
2. INST. OF MED., KEY CAPABILITIES OF AN ELECTRONIC HEALTH RECORD SYSTEM 1–2 
(2003) (stating that “[t]here is a great deal of interest within both the public and private 
sectors in encouraging all health care providers to migrate from paper-based health records 
to a system that stores health information electronically and employs computer-aided deci-
sion support systems” and that the “development of an IT infrastructure has enormous po-
tential to improve the safety, quality, and efficiency of health care in the United States”); see 
also THE LEWIN GROUP, HEALTH INFORMATION TECHNOLOGY LEADERSHIP PANEL FINAL 
REPORT 3 (2005) (recognizing “HIT implementation as an essential, high priority for health 
care”).  
3. Editorial, World’s Best Medical Care?, N.Y. TIMES, Aug. 12, 2007, at WK9. France 
and Italy were ranked first and second. Id. 
4. Id. The editorial also argued that “despite our vaunted prowess in computers, software 
and the Internet, much of our health care system is still operating in the dark ages of paper 
records and handwritten scrawls.” Id. 
5. Ambulatory care is treatment that is given at the office of a physician or other pro-
vider. See STEDMAN’S MEDICAL DICTIONARY 59 (28th ed. 2005) (defining “ambulatory” as 
“denoting a patient who is not confined to bed or hospital as a result of disease or surgery”). 
6. See AM. HOSP. ASS’N, CONTINUED PROGRESS: HOSPITAL USE OF INFORMATION 
TECHNOLOGY 1 (2007), available at http://www.aha.org/aha/content/2007/pdf/070227- 
continuedprogress.pdf; Catherine M. DesRoches et al., Electronic Health Records in Ambu-
latory Care — A National Survey of Physicians, 359 NEW ENG. J. MED. 50, 54 (2008). For 
further discussion of how many health care providers currently use EHR systems, see infra 
notes 149–53 and accompanying text. 
7. TO ERR IS HUMAN: BUILDING A SAFER HEALTH SYSTEM 1–2 (Linda T. Kohn et al. 
eds., 2000). 
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EHR system, to identify 17,000 patients who needed to be re-
vaccinated.8  
An emergency room doctor at a large Texas hospital also pro-
vided two vivid illustrations of the need for EHR systems from his 
personal experience.9 In one case, a woman with a splint on her arm 
stated that she had a broken arm, was suffering severe discomfort, and 
had run out of the painkillers she was given when initially treated at 
another hospital. In the absence of access to the other hospital’s re-
cords, the doctor ordered X-rays of her arm and neck, only to discover 
that she had no injury. The time and expense wasted in uncovering the 
woman’s scheme to obtain prescription narcotics could have been 
avoided had the physician been able to discredit her claim through a 
search of electronic records. In a second instance, the doctor treated a 
paraplegic patient who had a urinary tract infection. Because he did 
not have access to the patient’s records at other facilities, the physi-
cian did not know that the infection, caused by the patient’s perma-
nent urinary catheter, was resistant to the antibiotics that he had 
prescribed. The patient died of heart failure in the hospital.  
Politicians and government leaders have expressed great enthusi-
asm for the development and implementation of EHR systems. In 
April 2004, President George W. Bush announced plans to ensure that 
most Americans’ health records are computerized within ten years10 
and to create a National Health Information Network (“NHIN”).11 
Numerous proposed bills have been introduced in Congress to pro-
mote HIT initiatives.12 Executive and legislative efforts at the state 
level have established strategies and target dates for HIT implementa-
tion, commissions to develop recommendations for HIT use, and fi-
nancial incentives for HIT adoption.13 EHR systems also became an 
issue in the 2008 presidential campaign, as both Senators McCain and 
Obama discussed their potential benefits.14   
                                                                                                                  
8. Meg Walker, Electronic Medical Records Can Cure Potential Nightmares, SAN 
FRANCISCO BUS. TIMES, Mar. 29, 2002, available at http://sanfrancisco.bizjournals.com/ 
sanfrancisco/stories/2002/04/01/newscolumn2.html.  
9. E-mail to Sharona Hoffman, Professor of Law, Case Western Reserve University Law 
School (Aug. 29, 2007, 22:46:00 EDT) (on file with author). 
10. The White House, A New Generation of American Innovation, Transforming Health 
Care: The President’s Health Information Technology Plan, 
http://www.whitehouse.gov/infocus/technology/economic_policy200404/chap3.html (last 
visited Dec. 19, 2008).  
11. Exec. Order No. 13,335, 69 Fed. Reg. 24,059 (Apr. 27, 2004); Nicolas P. Terry & 
Leslie P. Francis, Ensuring the Privacy and Confidentiality of Electronic Health Records, 
2007 U. ILL. L. REV. 681, 686. 
12. See infra notes 160–62 and accompanying text. 
13. National Conference of State Legislatures, Health Information Technology Financing 
Legislation, http://www.ncsl.org/programs/health/forum/Hitch/finance.htm (last visited Dec. 
19, 2008).  
14. Editorial, The Candidates’ Health Plans, N.Y. TIMES, Oct. 28, 2008, at A30 ("Both 
candidates have largely accepted the prevailing expert wisdom on ways to improve quality 
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However, the novel and significant risks generated by EHR sys-
tems cannot be ignored.15 Products with poor information display and 
navigation can impede rather than facilitate providers’ work.16 The 
growing capabilities of EHR systems require increasingly complex 
software, which heightens the danger of software failures that may 
harm patients. To illustrate, one report relates that a hospital phar-
macy’s computer program generated erroneous medication order lists, 
leading to the delivery of the wrong drugs to patients in many wards.17  
Thus far, the legal literature has not assessed the need for careful 
regulatory oversight of EHR systems akin to that required, in princi-
ple, by the Food and Drug Administration (“FDA”) for life-critical 
medical devices.18 This Article begins to fill that gap. It analyzes EHR 
systems from both legal and technical perspectives and examines how 
law can serve as a tool to promote HIT. Extensive regulations already 
exist to govern the privacy and security of electronic health informa-
tion.19 Privacy and security, however, are only two of the concerns 
that merit regulatory attention. Perhaps even more important are the 
safety and efficacy of these life-critical systems. 
The benefits of EHR systems will outweigh their risks only if 
these systems are developed and maintained with rigorous adherence 
to the best software engineering and medical informatics practices and 
if the various EHR systems can easily share information with each 
other. Regulatory intervention is needed to ensure that these goals are 
achieved. Once EHR systems are fully implemented, they become 
essential to proper patient care, and their failure is likely to endanger 
patient welfare.20  
                                                                                                                  
and lower health care costs over the long run, such as relying more on electronic medical 
records and better management of the chronically ill."). 
15. See infra notes 102–13 and accompanying text; INTEGRATED CTR. FOR CARE 
ADVANCEMENT THROUGH RESEARCH ET AL., THE RELATIONSHIP BETWEEN ELECTRONIC 
HEALTH RECORDS AND PATIENT SAFETY: A JOINT REPORT ON FUTURE DIRECTIONS FOR 
CANADA 7 (2007), available at http://www.infoway-inforoute.ca/Admin/Upload/Dev/ 
Document/EHR-Patient%20Safety%20Report.pdf (asserting that there is “evidence to sug-
gest that EHRs may facilitate medical errors and/or generate new kinds of errors”). 
16. See Pamela Hartzband & Jerome Groopman, Off the Record — Avoiding the Pitfalls 
of Going Electronic, 358 NEW ENG. J. MED. 1656, 1657 (2008) (“[I]n the new electronic sea 
of results, it becomes difficult to find those that are truly relevant”); Christine A. Sinsky, e-
Nirvana: Are We There Yet?, 15 FAM. PRAC. MGMT. 6, 6 (2008), available at 
http://www.aafp.org/fpm/20080300/6enir.html (arguing that existing EHR systems have 
severe usability problems and provide poor support to physicians). 
17. Richard I. Cook & Michael F. O’Connor, Thinking About Accidents and Systems, in 
IMPROVING MEDICATION SAFETY 80–82 (Kasey Thompson & Henri R. Manasse eds., 2005) 
(explaining that the problem was rooted in a backup tape that was incomplete and cor-
rupted). 
18. See infra Part III.B.1 for discussion of FDA’s regulation of medical devices. 
19. See infra notes 119–28 and accompanying text (discussing the HIPAA Privacy and 
Security rules). 
20. See Frank Richards, Infrastructure, in IMPLEMENTING AN ELECTRONIC HEALTH 
RECORD SYSTEM 21, 21 (James M. Walker et al. eds., 2005) [hereinafter IMPLEMENTING AN 
EHR SYSTEM] (explaining that “falling back on manual processes when the automated 
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The remainder of the Article will proceed as follows: Part II pro-
vides background and analysis of EHR systems, including their bene-
fits and risks. Part III assesses the need for regulatory oversight of 
EHR systems. Part IV develops detailed recommendations for the 
contents of a regulatory framework. These recommendations include a 
requirement that all health care providers use approved EHR systems 
and that the government provide financial assistance to support the 
implementation of the new systems. In addition, the proposal ad-
dresses the following: the selection of an agency to regulate EHR sys-
tems; the creation of approval and monitoring processes for EHR 
systems; the standardization of system features and capabilities; inter-
operability; and the establishment of a national research databank of 
de-identified21 electronic patient records. Part V concludes. 
II. EHR SYSTEMS: BACKGROUND AND ANALYSIS 
A. What Are EHR Systems? 
No universally accepted definitions have been developed for 
“EHRs” or “EHR systems.”22 There is, however, some agreement 
about their essential components.23 EHR systems, as the term is used 
in this Article and by other commentators, do much more than keep 
records.24 In 2003, the Institute of Medicine (“IOM”) identified the 
following elements as “core EHR functionalities”: 
 
• Health information and data: The system should display la-
boratory test results, allergies, lists of other medications the 
patient is taking, medical and nursing diagnoses, patient de-
mographics, and providers’ notes.25 
• Results management: EHRs should provide laboratory test re-
sults, radiology procedure results, and other treatment results 
                                                                                                                  
system is down is problematic at best, and, in the worst case, may compromise patient 
care”). 
21. De-identified medical records are records that do not explicitly identify individuals 
and cannot be used to identify individuals (e.g., through social security numbers, addresses, 
etc.). See 45 C.F.R. § 164.514(a) (2007). 
22. See Ashish K. Jha et al., How Common Are Electronic Health Records in the United 
States? A Summary of the Evidence, 25 HEALTH AFF. w496, w497 (2006); see also ROBERT 
WOOD JOHNSON FOUND. ET AL., HEALTH INFORMATION TECHNOLOGY IN THE UNITED 
STATES: THE INFORMATION BASE FOR PROGRESS 8 (2006), available at 
http://www.rwjf.org/files/ 
publications/other/EHRReport0609.pdf (noting the “need to develop a common, valid defi-
nition of an EHR”). 
23. Jha et al., supra note 22, at w497. 
24. See BIOMEDICAL INFORMATICS, supra note 1, at 937 (noting that EHR systems in-
clude “information management tools that provide clinical alerts and reminders, linkages 
with external health knowledge sources, and tools for data analysis”). 
25. INST. OF MED., supra note 2, at 7. 
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electronically to enhance provider access to needed informa-
tion and promote efficiency and easier detection of abnor-
malities.26 
• Order entry and management: Computerized medication or-
ders and other care instructions can reduce or eliminate lost 
orders, duplicate orders, mistakes caused by illegible hand-
writing, and delays in filling orders.27 
• Decision support: Computer reminders and prompts can im-
prove preventive care, diagnosis, treatment, and disease man-
agement.28 
• Electronic communication and connectivity: EHR systems 
should facilitate online communication among medical team 
members, other providers such as laboratories or pharmacies, 
and patients through e-mail, web messaging, integrated health 
records within and across treatment settings, telemedicine,29 
and home telemonitoring.30 Communication should be possi-
ble among providers in different geographic locations and 
medical organizations.31 
 
With these features, EHR systems can significantly improve med-
ical treatment by ensuring that patients’ health information is easily 
available to providers who require it, by preventing or correcting cli-
nicians’ errors or oversights before they cause harm, and by helping to 
promulgate best medical practices. In addition, EHR systems can 
serve important administrative functions:  
 
• Patient support: Patient education and self-testing at home 
should be facilitated by electronic systems.32 
• Administrative processes: Electronic scheduling systems, in-
surance eligibility verification, billing, and claims processing 
systems should be components of EHRs. Computerized tools 
can also be used to identify individuals who are potentially 
eligible for clinical trials, those who should be informed 
about a drug recall, or candidates for chronic disease man-
agement programs.33 
                                                                                                                  
26. Id. at 7–8. 
27. Id. at 8. 
28. Id. at 8–9. 
29. Telemedicine is “the delivery of health care at a distance, increasingly but not exclu-
sively by means of the Internet.” BIOMEDICAL INFORMATICS, supra note 1, at 991. 
30. Home telemonitoring can be defined as “an automated process for the transmission of 
data on a patient’s health status from home to the . . . health care setting.” Guy Paré et al., 
Systematic Review of Home Telemonitoring for Chronic Diseases: The Evidence Base, 14 J. 
AM. MED. INFORMATICS ASS’N 269, 270 (2007). 
31. INST. OF MED., supra note 2, at 9–10. 
32. Id. at 10. 
33. Id. 
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• Reporting and population health management: Through the 
implementation of standardized terminology and machine-
readable records, EHR systems should enable providers to 
collect clinical data in order to meet public and private report-
ing requirements.34 
 
The federal government’s ultimate goal is a fully interoperable 
EHR system. The system will initially operate on a regional basis us-
ing Regional Health Information Organizations (“RHIOs”) and even-
tually transition to an NHIN.35 “Interoperability” means “the ability 
for systems to exchange data and to operate in a coordinated, seamless 
manner.”36 If EHR systems across the country are made interoperable, 
patients who relocate to different cities or seek second opinions from 
doctors outside their physician networks could have their records elec-
tronically transmitted to the new physicians, who could use them on 
their own EHR systems. 
One well known RHIO is the Regenstrief Medical Record Sys-
tem, which is used by numerous facilities in the Indianapolis area.37 
The system captures medical data, includes an order entry mechanism, 
provides reminders and informational feedback, and features search 
and retrieval capabilities for research purposes.38 The largest EHR 
system in the U.S. is the Veterans Health Information Systems and 
Technology Architecture (“VistA”) developed by the Department of 
Veterans’ Affairs (“VA”). A primary component of VistA is a physi-
cian interface called the Computerized Patient Record System 
(“CPRS”).39 The CPRS, which has been widely praised,40 provides 
complete EHRs, an order entry system, critical alerts, remote access to 
health information at other VA facilities, and decision support, includ-
ing reminders.41  
                                                                                                                  
34. Id. at 10–11. 
35. Jeff Day, Regional EHR Exchanges to Lead U.S. Drive, Some Say; Others See Ques-
tionable Future, 15 BNA’S HEALTH CARE POL’Y REP. 1011, 1011 (2007); Terry & Francis, 
supra note 11, at 686. 
36. BIOMEDICAL INFORMATICS, supra note 1, at 952. 
37. See Clement J. McDonald et al., The Regenstrief Medical Record System: A Quarter 
Century Experience, 54 INT’L J. MED. INFORMATICS 225, 226–28 (1999). 
38. Id. at 225–27, 248. 
39. See Jonathan B. Perlin et al., The Veterans Health Administration: Quality, Value, 
Accountability, and Information as Transforming Strategies for Patient-Centered Care, 
10 AM. J. MANAGED CARE 828, 828, 832 (2004). See generally DEP’T OF VETERANS 
AFFAIRS, COMPUTERIZED PATIENT RECORD SYSTEM (CPRS) USER GUIDE (2008) (on file 
with the author) [hereinafter CPRS USER GUIDE] (describing the VA’s CPRS and its fea-
tures). 
40. See, e.g., Joel Kupersmith et al., Advancing Evidence-Based Care for Diabetes: Les-
sons from the Veterans Health Administration, 26 HEALTH AFF. w156, w156 (2007) (stating 
that the VA’s Veterans Health Administration provides “a unique laboratory for using the 
[EHR] to transform health care and accelerate discovery”); Perlin et al., supra note 39, at 
832. 
41. Perlin et al., supra note 39, at 832–33. 
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Some current HIT initiatives utilize two alternatives to compre-
hensive EHRs: continuity of care records (“CCRs”) and personal 
health records (“PHRs”).42 CCRs are summaries that aggregate data 
from a variety of sources to form a limited record of the patient’s pro-
vider and insurance information, current health care status, and medi-
cal history, including allergies, medications, diagnoses, and recent 
procedures.43 These subsets of full patient EHRs can be e-mailed to 
the patient’s next care giver or given to the patient on paper or port-
able electronic media to be taken to her next appointment.44 While 
useful, CCRs are not as comprehensive as full EHRs, and, unlike 
EHR systems, CCRs do not offer order entry mechanisms, decision 
support, or interoperability, all of which provide significant benefits to 
patients and clinicians.45 
PHRs contain medical and claims information that is collected 
and maintained by patients who may then share this information with 
other parties, including employers, insurers, and private enterprises.46 
One source describes the PHR as follows: 
 
[A]n Internet-based set of tools that allows people to 
access and coordinate their lifelong health informa-
tion and make appropriate parts of it available to 
those who need it. PHRs offer an integrated and 
comprehensive view of health information, including 
information people generate themselves such as 
symptoms and medication use, information from 
doctors such as diagnoses and test results, and in-
formation from their pharmacies and insurance com-
panies. Individuals access their PHRs via the 
                                                                                                                  
42. Terry & Francis, supra note 11, at 687–88. 
43. CTR. FOR HEALTH INFO. TECH., ESSENTIAL SIMILARITIES AND DIFFERENCES 
BETWEEN THE HL7 CDA/CRS AND ASTM CCR 1–2 (2005), available at 
http://www.centerforhit.org/PreBuilt/chit_ccrhl7.pdf; Lynda C. Burton et al., Using Elec-
tronic Health Records to Help Coordinate Care, 82 MILBANK Q. 457, 461 (2004). 
44. Burton et al., supra note 43, at 461. 
45. See supra note 36 and accompanying text (discussing interoperability); infra Parts 
II.B.2, IV.C.2, and IV.C.5 (discussing computerized order entry, decision support, and 
interoperability). 
46. Terry & Francis, supra note 11, at 688; see also Private Health Records: Privacy Im-
plications of the Federal Government’s Health Information Technology Initiative: Hearing 
Before the S. Comm. on Homeland Security and Governmental Affairs, 110th Cong. 5–6 
(2007) [hereinafter Private Health Records] (testimony of Mark A. Rothstein, Director, 
University of Louisville School of Medicine), available at http://hsgac.senate.gov/ 
public/_files/testimonyrothstien.pdf; Press Release, BlueCross BlueShield Association, 
BlueCross Introduces Personal Health Record for Fully-Insured Members (Sept. 20, 2006), 
available at http://www.bcbs.com/news/plans/bluecross-introduces-personal-health-
records.html. 
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Internet, using state-of-the-art security and privacy 
controls . . . .47  
Wal-Mart and other large employers, such as Intel and BP, with a 
total of 2.5 million employees, have formed a PHR system named 
Dossia.48 Both Google and Microsoft have developed products that 
enable customers to maintain PHRs.49  
However, stand-alone PHRs may be of limited use. To the extent 
data is entered by patients themselves, they may often be incomplete 
or inaccurate.50 Furthermore, without interoperability and the capacity 
to exchange data with EHR systems operated by all facilities at which 
the patient receives care, PHRs would constitute isolated and partial 
records, because they could not be accessed by all physicians and 
could not be updated with each new patient encounter.51 Finally, 
stand-alone PHRs will not offer some of the most important benefits 
of EHR systems, including decision support and order entry. Conse-
quently, some commentators assert that PHRs will be of significant 
benefit to patients and caregivers only if they are integrated into pro-
viders’ EHR systems.52 
B. Benefits of EHR Systems 
Many experts have justifiably expressed strong enthusiasm for 
EHR systems, and many policy makers have asserted a commitment 
to promote their broad adoption.53 These systems could facilitate cli-
nicians’ access to critical patient information and could prevent medi-
                                                                                                                  
47. PERSONAL HEALTH WORKING GROUP, MARKLE FOUND., THE PERSONAL HEALTH 
WORKING GROUP FINAL REPORT 3 (2003), available at http://www.markle.org/ 
downloadable_assets/final_phwg_report1.pdf.  
48. Private Health Records, supra note 46, at 6. 
49. See Steve Lohr, Dr. Google and Dr. Microsoft, N.Y. TIMES, Aug. 14, 2007, at C1; 
see also Martha Kessler, Aetna Joins With Microsoft to Provide Portable Health Records 
for Members, 16 BNA’S HEALTH CARE POL’Y REP. 1456 (2008); Google Health, 
http://www.google.com/health (last visted Dec. 19, 2008); Posting of Steve Lohr to NY-
Times.com Bits Blog, Google Health Begins Its Preseason at Cleveland Clinic, 
http://bits.blogs.nytimes.com/2008/02/21/google-health-begins-its-preseason-at-cleveland-
clinic (Feb. 21, 2008, 1:13 EST) (discussing a pilot project in which the health information 
of ten thousand Cleveland Clinic patients would be linked with Google PHRs).  
50. Paul C. Tang et al., Personal Health Records: Definitions, Benefits, and Strategies 
for Overcoming Barriers to Adoption, 13 J. AM. MED. INFORMATICS ASS’N 121, 122 (2006) 
(asserting that “it is unlikely that individuals would keep records . . . up to date” and that 
“most patients cannot reliably report specific laboratory values such as their specific choles-
terol level or hemoglobin A1c”). 
51. Id. at 124 (explaining that PHRs could “become ‘information islands’ that contain 
subsets of patients’ data, isolated from other information about patients, with limited access 
and transient value”). 
52. See, e.g., id. (“[A]ll the advantages of PHRs for providers depend on the PHR being 
integrated with the provider’s EHR.”). 
53. See supra notes 10–14 and accompanying text. 
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cal errors, thereby potentially saving thousands of lives and billions of 
dollars.54 
This Section describes the numerous benefits of EHR systems, 
which could dramatically improve health care in the U.S. and world-
wide. These benefits support the widespread adoption of EHR sys-
tems and the establishment of an NHIN. 
1. Facilitating Access to Patients’ Medical Records 
EHR systems enable health care providers to obtain critical medi-
cal information about their patients as soon as the need for it arises. 
Essential to this capacity is interoperability.55 
Interoperable EHR systems could allow doctors with proper au-
thorization to access to relevant information about their patients, in-
cluding medical histories, drug lists, and allergies, no matter where 
the patients had been previously treated. This capability could be in-
valuable in treating patients who arrive at the emergency room uncon-
scious. It could also significantly facilitate and enhance the treatment 
of economically disadvantaged patients, who may not have attentive 
primary care physicians to manage their care56 and who may not fully 
recall or understand the details of their medical histories.  
Many patients who are not economically disadvantaged also have 
records that are fragmented and not fully accessible to all physicians 
treating them. According to one source, the average patient on Medi-
care visits seven different physicians every year.57 If these doctors do 
not communicate and carefully coordinate the patient’s care, any one 
of them may miss vital information that is critical to the individual’s 
welfare. 
An additional strength of EHRs is that, if appropriately backed up 
or replicated, they should be less vulnerable to loss or destruction than 
paper records. This problem with paper records was highlighted in the 
aftermath of Hurricane Katrina, when the medical records of many 
displaced New Orleans residents were destroyed.58 
                                                                                                                  
54. See TO ERR IS HUMAN: BUILDING A SAFER HEALTH SYSTEM, supra note 7, at 1–2. 
55. See supra note 36 and accompanying text. 
56. See Lawrence O. Gostin, “Police” Powers and Public Health Paternalism: HIV and 
Diabetes Surveillance, 37 HASTINGS CENTER REP. 9, 10 (2007) (“Most poor people do not 
enjoy the benefits of education and income that enable them to form stable physician-patient 
relationships and comply with complex treatment regimes.”). 
57. DANIEL CASTRO, INFO. TECH. & INNOVATION FOUND., IMPROVING HEALTH CARE: 
WHY A DOSE OF IT MAY BE JUST WHAT THE DOCTOR ORDERED 3 (2007), available at 
http://www.itif.org/files/HealthIT.pdf. 
58. See Olga Pierce, Analysis: The Medical Record Paper Chase, UPI, Sept. 15, 2006, 
LEXIS, News Library, UPI File; see also Jeff Day, Group Finds Support for E-Health Re-
cords, ‘Medical Home’ Clinics Following Hurricane, 15 BNA’S HEALTH CARE POL’Y REP. 
716, 716 (2007).  
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2. Improving Quality of Care and Reducing Poor Treatment Decisions 
EHR systems can reduce errors and thereby improve patient safe-
ty, particularly through decision support features.59 Decision support 
is “any information added by a system to assist the clinician’s deci-
sion-making process.”60 EHR systems can incorporate reminders, 
prompts, and links to medical literature to promote accurate, timely, 
and responsible care.61 Studies have shown that computerized re-
minder systems improve immunization rates, preventive care, clini-
cian adherence to practice guidelines, and the thoroughness of patient 
histories.  Studies have also shown that EHR systems reduce prescrib-
ing costs, prescribing mistakes, and unneeded diagnostic tests.62 Ac-
cording to one source, computerized physician order entry (“CPOE”) 
systems could likely prevent sixty-five percent of prescribing errors, 
largely by incorporating decision support features that would educate 
doctors about medications.63 In one instance, for example, a doctor 
typed a prescription for ten times the proper dosage, and the EHR sys-
tem informed him of the error.64  
                                                                                                                  
59. See Basit Chaudhry et al., Systematic Review: Impact of Health Information Technol-
ogy on Quality, Efficiency, and Costs of Medical Care, 144 ANNALS INTERNAL MED. 742, 
748 (2006) (citing the benefits of “increased delivery of care based on guidelines . . . , re-
duction of medication errors, and decreased rates of utilization for potentially redundant or 
inappropriate care”); see also INST. OF MED., supra note 2, at 5. But see infra Part II.C.1 for 
discussion of the possibility that EHR systems might sometimes cause errors instead of 
preventing them. 
60. Jonathan A. Handler et al., Computerized Physician Order Entry and Online Decision 
Support, 11 ACAD. EMERGENCY MED. 1135, 1135 (2004). 
61. See Anne Bobb et al., The Epidemiology of Prescribing Errors: The Potential Impact 
of Computerized Prescriber Order Entry, 164 ARCHIVES INTERNAL MED. 785, 788–89 
(2004); Richard Hillestad et al., Can Electronic Medical Record Systems Transform Health 
Care? Potential Health Benefits, Savings, and Costs, 24 HEALTH AFF. 1103, 1110 (2005); 
Jeffrey A. Linder, Health Information Technology as a Tool to Improve Care for Acute 
Respiratory Infections, 10 AM. J. MANAGED CARE 661, 661 (2004). 
62. See Burton et al., supra note 43, at 461, 464; see also Paul R. Dexter et al., A Com-
puterized Reminder System to Increase the Use of Preventive Care for Hospitalized Pa-
tients, 345 NEW ENG. J. MED. 965, 968 (2001) (finding that “the use of reminders increased 
the use of pneumococcal and influenza vaccination from practically zero to approximately 
35 percent and 50 percent, respectively” for hospitalized patients); Elizabeth Mitchell & 
Frank Sullivan, A Descriptive Feast but an Evaluative Famine: Systematic Review of Pub-
lished Articles on Primary Care Computing During 1980–97, 322 BRIT. MED. J. 279, 281 
(2001) (describing “improvements in immunisations and preventive care and reductions in 
prescribing costs and unnecessary tests” due to computerization); Mike Pringle, Using Com-
puters to Take Patient Histories, 297 BRIT. MED. J. 697, 697 (1988) (“Computer histories 
are more exhaustive than those taken in the normal way.”); Charles Safran et al., Guidelines 
for Management of HIV Infection with Computer-Based Patient’s Records, 346 LANCET 
341, 344 (1995) (concluding that EHR systems help clinicians to adhere to practice guide-
lines). 
63. Bobb et al., supra note 61, at 788. 
64. Ceci Connolly, Cedars-Sinai Doctors Cling to Pen and Paper, WASH. POST, Mar. 21, 
2005, at A01. 
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EHR systems might also dissuade physicians from practicing 
wasteful “defensive medicine.”65 Clinicians could rely on decision 
support mechanisms to determine whether particular diagnostic pro-
cedures or treatments are warranted. Because these mechanisms 
would be designed based on widely accepted medical practices, the 
doctors could, if necessary, cite their reliance on the mechanisms to 
defend their medical decisions. 
Likewise, the systems could reduce the unnecessary use of antibi-
otics. One study found that seventy-three percent of adults who visit 
primary care physicians for sore throats are treated with antibiotics, 
even though only five to seventeen percent of adults’ sore throats re-
quire antibiotic therapy.66 The excessive use of broad spectrum anti-
biotics has led to the emergence of antibiotic-resistant bacteria.67 This 
phenomenon might become less common with the assistance of deci-
sion support systems designed to provide guidance concerning pre-
scription drugs. 
Currently, the lag between the discovery of new treatments and 
their consistent use in medical practice can be up to twenty years.68 
EHR systems, however, could significantly expedite the broad dis-
semination of knowledge about effective new treatments through de-
cision support mechanisms.69 
Furthermore, by allowing physicians to search patient records 
electronically for the information they require, EHR systems can re-
duce the amount of time providers spend reviewing patients’ medical 
histories.70 In addition, electronic searches can allow clinicians to 
                                                                                                                  
65. See David M. Studdert et al., Defensive Medicine Among High-Risk Specialist Physi-
cians in a Volatile Malpractice Environment, 293 JAMA 2609, 2609 (2005) (noting that 
defensive medicine is prevalent among Philadelphia physicians in specialties with a high 
risk of litigation). “Defensive medicine” is the practice of making healthcare decisions “with 
the sole intention of preventing” malpractice lawsuits and can include the provision of ex-
cessive unnecessary care or the avoidance of beneficial treatment that is high-risk. G.D. 
Dalton et al., Effect of Physician Strategies for Coping with the US Medical Malpractise 
Crisis on Healthcare Delivery and Patient Access to Healthcare, 122 PUB. HEALTH 1051, 
1054–55 (2008). 
66. Jeffrey A. Linder & Randall S. Stafford, Antibiotic Treatment of Adults With Sore 
Throat by Community Primary Care Physicians: A National Survey 1989–1999, 286 JAMA 
1181, 1185 (2001) (providing statistics regarding the use of antibiotics); see also Richard E. 
Besser, Editorial, Antimicrobial Prescribing in the United States: Good News, Bad News, 
138 ANNALS INTERNAL MED. 605, 605 (2003) (“[I]n 1992, the U.S. Centers for Disease 
Control and Prevention (CDC) stated that over 40% of antimicrobial courses prescribed in 
physicians’ offices were inappropriate.”). 
67. See Besser, supra note 66, at 605. 
68. COMM. ON QUALITY OF HEALTH CARE IN AM., INST. OF MED., CROSSING THE 
QUALITY CHASM: A NEW HEALTH SYSTEM FOR THE 21ST CENTURY 145 (2001) [hereinafter 
CROSSING THE QUALITY CHASM]. 
69. See Louise Liang, The Gap Between Evidence and Practice, 26 HEALTH AFF. w119, 
w120 (2007). 
70. See Richard J. Baron et al., Electronic Health Records: Just Around the Corner? Or 
over the Cliff?, 143 ANNALS INTERNAL MED. 222, 225–26 (2005). 
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identify patients who should be informed about matters such as drug 
recalls.71 
Of particular significance is the potential role of these systems in 
reducing health disparities in the U.S.72 Health disparities between 
whites and blacks have been the subject of much commentary and 
debate in recent years.73 Technology that provides resource-poor prac-
tices with automatic decision support, reminders, and alerts based on 
the most advanced medical knowledge could enhance the care avail-
able to economically disadvantaged patients. With affordable or sub-
sidized EHR systems, clinicians who are pressed for time and 
resources would have information at their fingertips that they might 
otherwise be unable to access. It must be noted, however, that, if only 
wealthy practices can afford EHR systems and others are left without 
the improvements they enable, the technology could increase health 
disparities between rich and poor communities. Consequently, it will 
be important to offer financial support for EHR system adoption to 
some practices.74 
EHR systems also have much to contribute to public health emer-
gency response efforts. EHR vendors75 and public health officials 
could use decision support functions in EHR systems to inform clini-
cians as to how best to respond to public health emergencies.76 For 
example, EHR systems nationwide might be quickly reconfigured to 
advise caregivers to treat patients with particular symptoms as possi-
ble carriers of an emerging infectious disease. 
3. Cost Savings 
Many commentators associate significant cost savings with EHR 
systems, despite the expenses of purchasing, implementing, and oper-
                                                                                                                  
71. See id. 
72. See Alexandra E. Shields et al., Adoption of Health Information Technology in Com-
munity Health Centers: Results of a National Survey, 26 HEALTH AFF. 1373, 1381 (2007) 
(stating that expanding HIT capacity “seems a valuable strategy to further reduce health 
disparities for a substantial number of financially vulnerable patients”). 
73. See, e.g., René Bowser, Racial Profiling in Health Care: An Institutional Analysis of 
Medical Treatment Disparities, 7 MICH. J. RACE & L. 79, 81 (2001) (positing an institu-
tional basis for white-black disparities in medical treatment); Ichiro Kawachi et al., Health 
Disparities by Race and Class: Why Both Matter, 24 HEALTH AFF. 343 (2005) (examining 
racial and class disparities in health); David Satcher et al., What if We Were Equal? A Com-
parison of the Black-White Mortality Gap in 1960 and 2000, 24 HEALTH AFF. 459 (2005) 
(discussing persistent racial inequalities in standardized mortality ratios over a forty year 
period). 
74. See infra Part IV.A.1. 
75. Throughout this Article we use the term “vendor” broadly to refer to those who de-
velop or modify EHR system software, install it, or integrate it with existing systems. Health 
care providers who perform these functions themselves should be deemed vendors for legal 
purposes relating to EHR system activities ordinarily performed by vendors. 
76. These adaptations could be similar to automatic anti-virus downloads, which are now 
commonly available. 
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ating them.77 Some commentators have estimated the net economic 
benefits of EHR implementation to range from $8400 to $140,100 per 
physician over five years.78 Others have found savings of $16.7 mil-
lion over ten years for a hospital operating a CPOE system.79 Still 
others have estimated $77.8 billion a year in savings for the institution 
of a standardized, interoperable national system.80 These cost savings 
result from: fewer duplicated tests; reduction in administrative expen-
ditures; a decrease in medical errors and adverse drug events linked to 
ignorance about the patient’s allergies, medical history, and other pre-
scription drugs; and, from the provider’s perspective, from improved 
mechanisms for calculating and recording charges.81 Doctors would 
be able to retrieve the EHRs of patients who present at emergency 
rooms no matter where those records are housed and thus would not 
need to conduct diagnostic tests that the patient has already recently 
undergone. Furthermore, access to a patient’s complete EHR, includ-
ing medical history, allergies, and current medication list, could pre-
vent medical errors in the emergency room that might lead to lengthy 
hospitalization, surgery, and other expensive care.  
Other commentators note, however, that to date there is a dearth 
of compelling empirical evidence that proves the cost-effectiveness of 
EHR systems.82 Indeed, because of the relatively low rate of EHR 
system adoption, to date there is only limited data concerning cost 
savings.83 The evidence base is likely to improve as more institutions 
adopt EHR systems and an increasing number of researchers and 
economists begin to study their impact. 
                                                                                                                  
77. See infra notes 131–33 and accompanying text for discussion of these costs. 
78. William W. Stead, Rethinking Electronic Health Records to Better Achieve Quality 
and Safety Goals, 58 ANN. REV. MED. 35, 37 (2007). 
79. Rainu Kaushal et al., Return on Investment for a Computerized Physician Order En-
try System, 13 J. AM. MED. INFORMATICS ASS’N 261, 265 (2006). 
80. Jan Walker et al., The Value of Health Care Information Exchange and Interoperabil-
ity, 25 HEALTH AFF. W5-10, W5-16 (2005). For a critique of estimates of savings generated 
by the proposed NHIN, see CONG. BUDGET OFFICE, EVIDENCE ON THE COSTS AND 
BENEFITS OF HEALTH INFORMATION TECHNOLOGY 8 (2008), available at  
http://www.cbo.gov/ 
ftpdocs/91xx/doc9168/05-20-HealthIT.pdf (discussing “estimates of the potential net bene-
fits that could arise nationwide if all providers and hospitals adopted health information 
technology”).  
81. See CONG. BUDGET OFFICE, supra note 80; Kaushal et al., supra note 79, at 263 tbl.1; 
Walker et al., supra note 80, at W5-16. 
82. S. Clamp & J. Keen, Electronic Health Records: Is the Evidence Base Any Use?, 
32 MED. INFORMATICS & INTERNET MED. 5, 9 (2007) (stating that the authors “found no 
technically sound evidence about cost changes associated with EHR”). 
83. Hillestad et al., supra note 61, at 1104 (“[T]he currently useful evidence [concerning 
HIT efficiency savings] is not robust enough to make strong predictions . . . .”).  
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4. Promoting Research 
EHRs could also promote medical research and the collection of 
much needed evidence concerning the efficacy of various treatment 
alternatives.84 The term of art for decision-making rooted in scientific 
knowledge is “evidence-based medicine,”85 a concept that is now fre-
quently discussed in academic and scientific circles.86 First, EHRs 
could facilitate the identification of patients for clinical studies by 
allowing investigators to search their patient records electronically for 
individuals who meet the inclusion criteria for particular clinical tri-
als. Second, many studies could be based directly on analysis of the 
extensive and comprehensive data contained in electronic records.87 
EHR systems should facilitate efficient and extensive collection of 
evidence and development of new knowledge.88 
Randomized, controlled clinical trials are considered the gold 
standard of medical studies.89 However, research can also be accom-
plished through observational studies, which could be facilitated by 
the use of EHRs.90 Rather than conducting a controlled experiment, 
investigators might review the charts or electronic files of patients 
receiving different medications or different types of surgery to treat a 
                                                                                                                  
84. See sources cited infra notes 386–87 (discussing the uncertainty surrounding many 
medical decisions). 
85. See Marc A. Rodwin, The Politics of Evidence-Based Medicine, 26 J. HEALTH POL. 
POL’Y & L. 439, 439 (2001) (explaining that “[e]vidence-based medicine is portrayed as an 
alternative to medicine based on authority, tradition, and the physician’s personal experi-
ence” and that it involves evaluating the “safety, effectiveness, and cost of medical practices 
using tools from science and social science”). 
86. See, e.g., Scott R. Sehon & Donald E. Stanley, A Philosophical Analysis of the Evi-
dence-Based Medicine Debate, 3 BMC HEALTH SERVICES RES. (2003), 
http://www.biomedcentral.com/1472-6963/3/14 (arguing that the medical community must 
clarify the “nature of [evidence-based medicine] and its relationship to alternative ap-
proaches to medicine”). 
87. See John Powell & Iain Buchan, Electronic Health Records Should Support Clinical 
Research, 7 J. MED. INTERNET RES. (2005), available at http://www.jmir.org/2005/1/e4/. 
88. Liang, supra note 69, at w120. 
89. Friedrich K. Port, Role of Observational Studies Versus Clinical Trials in ESRD Re-
search, 57 KIDNEY INT’L (SUPPLEMENT 74) S3, S3 (2000), available at 
http://www.nature.com/ki/journal/v57/n74s/pdf/4491615a.pdf (“Randomized controlled 
clinical trials have been considered by many to be the only reliable source for information in 
health services research.”). Experimental studies involve “the collection of data on a process 
when there is some manipulation of variables that are assumed to affect the outcome of a 
process, keeping other variables constant as far as possible.” BRYAN F.J. MANLY, THE 
DESIGN AND ANALYSIS OF RESEARCH STUDIES 1 (1992). 
90. CHARLES P. FRIEDMAN & JEREMY C. WYATT, EVALUATION METHODS IN 
BIOMEDICAL INFORMATICS 369 (2d ed. 2006) (defining an observational study as an 
“[a]pproach to study design that entails no experimental manipulation” in which 
“[i]nvestigators typically draw conclusions by carefully observing [subjects] with or without 
an information resource”); MANLY, supra note 89, at 1 (explaining that observational stud-
ies involve the collection of data “by observing some process which may not be well-
understood”). 
No. 1] Electronic Health Record Systems 17 
 
particular condition in order to determine the efficacy of each ap-
proach.91 
At times, observational studies may be skewed by uncontrolled 
variables, such as changes in diet, exercise, stress level, or other life-
style modifications that are not noted in the record and of which re-
searchers remain unaware.92 However, observational studies may also 
have several advantages over clinical trials. Interoperable systems can 
allow researchers to access vast amounts of information about various 
subpopulations over long periods of time.93 Researchers can monitor 
patients for years after drugs have been approved by the FDA and 
detect patterns of adverse events, avoiding continued harm to patients 
such as that caused by ignorance about the side effects of Vioxx.94 
These studies can also be considerably less costly and time-
consuming than experimental research because the data used already 
exist95 and investigators need not comply with federal research regula-
tions or obtain approval from Institutional Review Boards (“IRBs”)96 
if records are de-identified.97 In addition, investigators could study the 
cases of individuals with very rare diseases that cannot be studied 
through large-scale clinical trials. Likewise, researchers could review 
the records of patients who receive care of varying quality, including 
substandard care. Such substandard care, which is at times provided in 
real world treatment settings, would not be provided in the controlled 
setting of a clinical trial.  
It is not anticipated that EHR-based observational studies would 
replace randomized clinical trials.98 However, observational studies 
are a valuable addition to the research toolkit.99 In the words of one 
                                                                                                                  
91. See, e.g., Kjell Benson & Arthur J. Hartz, A Comparison of Observational Studies 
and Randomized, Controlled Trials, 342 NEW ENG. J. MED. 1878, 1879–83 (2000). 
92. See MANLY, supra note 89, at 4–5 (“[A] prima facie conclusion may be invalid be-
cause of the confounding effects of uncontrolled variables.”); Benson & Hartz, supra note 
91, at 1878 (“Concern about inherent bias [in observational studies] has limited their use in 
comparing treatments”); Gary Taubes, Do We Really Know What Makes Us Healthy?, N.Y. 
TIMES, Sept. 16, 2007, § 6 (Magazine), at 52 (describing the limitations of observational 
studies and stating that they “can only provide what researchers call hypothesis-generating 
evidence — what a defense attorney would call circumstantial evidence”). 
93. See Liang, supra note 69, at w120 (“EHRs have the potential to take over where clin-
ical trials and evidence-based research leave off, by providing real-world evidence of drugs’ 
and treatments’ effectiveness across subpopulations and over longer periods of time.”). 
94. Lynn M. Etheredge, A Rapid-Learning Health System, 26 HEALTH AFF. w107, w111 
(2007). 
95. Benson & Hartz, supra note 91, at 1878; Port, supra note 89, at S3. 
96. 21 C.F.R. § 56.102(g) (2007) (“Institutional Review Board (IRB) means any board, 
committee, or other group formally designated by an institution to review, to approve the 
initiation of, and to conduct periodic review of, biomedical research involving human sub-
jects.”). 
97. See infra note 394 and accompanying text (discussing regulatory requirements for the 
approval of research studies). 
98. See, e.g., Etheredge, supra note 94, at w108. 
99. See Port, supra note 89, at S5 (arguing that both observational studies and clinical 
studies have their place and complement each other); see also Jerry Avorn, In Defense of 
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commentator, EHRs “will offer the capacity for real-time learning 
from the experience of tens of millions of people and will greatly in-
crease the ability to generate and test hypotheses.”100  
C. The Challenges of EHR System Implementation 
Despite the many potential benefits of EHR systems, they are not 
an unalloyed good. Their design, implementation, use, and mainte-
nance raise important concerns that must not be overlooked. EHR 
system failures can cause significant injury and cost lives. Unauthor-
ized disclosure of electronic health information can also lead to large 
scale privacy breaches, and the cost of implementing EHR systems 
may threaten the financial viability of some medical practices. The 
risks generated by these complex software systems are sufficiently 
serious that they demand regulatory oversight.101  
1. Potential for Errors 
In some instances, EHR systems may generate errors rather than 
prevent them, especially early in the adoption process.102 Many of 
these errors could significantly harm patients. One study of a hospi-
tal’s CPOE system identified twenty-two circumstances in which 
CPOE increased rather than decreased the likelihood of error.103 
Sources of such errors include: fragmentation of data; failure to inte-
grate all hospital systems; and human-computer interface difficulties 
rooted in the machine rules’ failure to reflect work organization or 
expected provider behavior.104 For example, errors can result from 
computer crashes or from maintenance shutdowns that lead to lost 
orders.105 They may also result from system inflexibilities that signifi-
cantly impede providers’ ability to enter nonstandard specifications or 
                                                                                                                  
Pharmacoepidemiology — Embracing the Yin and Yang of Drug Research, 357 NEW ENG. 
J. MED. 2219, 2220 (2007) (listing the strengths and weaknesses of clinical and observa-
tional studies of medications); Benson & Hartz, supra note 91, at 1878, 1884 (concluding, 
based on a literature review, that “observational studies and randomized controlled trials 
usually produce similar results”).  
100. Etheredge, supra note 94, at w108. 
101. See infra Part III.A.2 (arguing for regulatory oversight of EHR systems). 
102. See Stead, supra note 78, at 38. 
103. Ross Koppel et al., Role of Computerized Physician Order Entry Systems in Facili-
tating Medication Errors, 293 JAMA 1197, 1199–201 (2005). 
104. Stead, supra note 78, at 38 (discussing human-computer interface problems); see 
Jonathan R. Nebeker et al., High Rates of Adverse Drug Events in a Highly Computerized 
Hospital, 165 ARCHIVES INTERNAL MED. 1111, 1114–15 (2005) (finding high rates of error 
at a hospital whose CPOE system did not have adequate decision support); Robert L. Wears, 
Computer Technology and Clinical Work, 293 JAMA 1261, 1262 (2005) (explaining that 
“the model of health care work inscribed” in CPOE and decision support systems clashes 
“with the actual nature of clinical work”). 
105. Koppel et. al., supra note 103, at 1201. 
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to order non-formulary medications.106 Usability problems, such as 
display and navigation deficiencies, can also cause errors.107 
Furthermore, complex software systems invariably exhibit a sig-
nificant degree of coupling or interdependence between their many 
components. Consequently, a failure of one component may cause or 
contribute to the failure of another component that is not obviously 
related to the first component.108 Similarly, complex software some-
times fails unpredictably due to unforeseen or untested interactions 
between its various features and services.109 Under certain conditions, 
a clearly safety-critical component of an EHR system, such as a diag-
nostic aid for cardiac care, might function incorrectly because of a 
subtle interaction with an apparently unrelated defective component, 
such as a billing feature.110  
Other errors may cause physicians to absorb financial losses. One 
physician reported that billing interface errors caused many of his 
patients to be improperly categorized as established rather than new 
patients, which resulted in a $90,000 revenue loss.111  
Some failures caused by flawed software design, implementation, 
or validation could be avoided with improved software engineering 
practices.112 However, as EHR system functionality becomes more 
complex, the safety risks to patients may grow unless additional qual-
ity control interventions are initiated.113 
                                                                                                                  
106. Id. Nonformulary medications are “[d]rugs not on a [health care] plan-approved 
drug list.” Medicare.gov — Glossary Definitions, http://www.medicare.gov/Glossary/ 
search.asp?SelectAlphabet=N&Language=English#Content (last visited Dec. 19, 2008).  
107. See Hartzband & Groopman, supra note 16, at 1657. 
108. See John Rushby, Critical System Properties: Survey and Taxonomy, 
43 RELIABILITY ENGINEERING & SYS. SAFETY 189, 210 (1994) (discussing coupling and 
explaining how tightness of coupling promotes efficiency but can cause unexpected failures 
in various system components). 
109. Dirk O. Keck & Paul J. Kuehn, The Feature and Service Interaction Problem in 
Telecommunications Systems: A Survey, 24 IEEE TRANSACTIONS ON SOFTWARE 
ENGINEERING 779, 779–80 (1998). 
110. Undesirable coupling and complex interactions between software components can 
be reduced by the application of certain software design techniques such as object-oriented 
design, but dependencies between components are an inherent aspect of software systems 
and cannot be eliminated or rendered insignificant. ERICH GAMMA ET AL., DESIGN 
PATTERNS: ELEMENTS OF REUSABLE OBJECT-ORIENTED SOFTWARE 24–25 (1999) (discuss-
ing design patterns that reduce coupling). 
111. Ken Terry, IT Implementation: Why EHRs Falter, MED. ECON., April 7, 2006, at 44, 
available at http://www.memag.com/memag/content/printContentPopup.jsp?id=316528. 
112. Madhavan Nayar & Sharon Miller, Anticipating Error: Identifying Weak Links in 
the Electronic Healthcare Environment, 75 J. AM. HEALTH INFO. MGMT. ASS’N 46, 47–49 
(2004) (discussing various factors that are intrinsic and extrinsic to EHR systems and create 
risks of error). 
113. See infra Parts IV.B and IV.C for recommendations. 
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2. Privacy and Security Concerns 
Both patients and analysts have expressed concern that EHR sys-
tems will threaten patient privacy and be vulnerable to security 
breaches.114 With a fully interoperable NHIN, EHRs could be ac-
cessed from anywhere in the country and transmitted illicitly across 
the world quickly, cheaply, and with little risk of detection.115 The 
security of health information is, in fact, compromised with alarming 
frequency as a result of computer theft, sale of used computers with-
out removal of data from hard drives, hacking, inadvertent disclo-
sures, and deliberate misuse of information by those with access to 
it.116 As an example, Georgetown University Hospital suspended a 
test program with electronic prescription provider InstantDx after a 
serious security breach was discovered in 2006.117 The hospital had 
securely transmitted data concerning thousands of patients to In-
stantDx, but, because of InstantDx’s flawed security practices, an 
Indiana consultant was able accidentally to stumble upon the online 
files while installing medical software for a client.118 
To address privacy and security concerns related to personal 
health information, the U.S. Department of Health and Human Ser-
vices (“HHS”) promulgated the Health Insurance Portability and Ac-
countability Act (“HIPAA”) Privacy Rule119 and the HIPAA Security 
Rule,120 the latter of which governs the security of certain electronic 
health information.121 We have critiqued these regulations at length in 
prior work and noted their shortcomings.122 The Privacy Rule covers 
only a narrow range of entities, namely health plans, health care clear-
inghouses, and health care providers who transmit health information 
electronically for claims, billing, or health plan purposes.123 It does 
not cover employers, marketers, life insurers, or many others who 
might handle personal health information. The Privacy Rule also does 
                                                                                                                  
114. Terry & Francis, supra note 11, at 696; National Committee on Vital and Health 
Statistics, Privacy and Confidentiality in the Nationwide Health Information Network 8–13 
(June 22, 2006), http://ncvhs.hhs.gov/060622lt.htm [hereinafter NCVHS] (“Protecting the 
confidentiality of personal health information in such settings requires institutions to estab-
lish different access rules depending on employees’ responsibilities and their need to know 
the information to carry out their role.”). 
115. Sharona Hoffman & Andy Podgurski, Securing the HIPAA Security Rule, J. 
INTERNET L., Feb. 2007, at 1, 6. 
116. Id. at 6. 
117. Kevin Poulsen, E-Health Gaffe Exposes Hospital, WIRED, July 25, 2006, 
http://www.wired.com/science/discoveries/news/2006/07/71453.  
118. Id. 
119. 45 C.F.R. §§ 160.101−.534 (2007). 
120. 45 C.F.R. §§ 160.302−.318 (2007). 
121. See Sharona Hoffman & Andy Podgurski, In Sickness, Health, and Cyberspace: 
Protecting the Security of Electronic Private Health Information, 48 B.C. L. REV. 331, 338–
44 (2007) (discussing the HIPAA Security Rule). 
122. Id. at 344–59. 
123. 45 C.F.R. § 160.103 (2007).  
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not feature a private cause of action,124 so its deterrent and remedial 
effects are limited.125 In addition, the Security Rule’s standards are 
extremely vague, leaving a vacuum of guidance that makes meaning-
ful compliance unlikely.126 A 2007 assessment of HIPAA compliance 
in fact found widespread confusion and mistakes.127 The standards in 
the HIPAA Privacy and Security Rules must be clarified, and their 
enforcement must be bolstered so that patient privacy and EHR confi-
dentiality are meaningfully protected.128 
Many states also have medical confidentiality rules that will af-
fect EHR systems.129 Because the NHIN would be an interstate net-
work allowing data that is entered in one location to be accessed 
anywhere in the U.S., some of the state standards may cause signifi-
cant complications and require modification in light of HIT develop-
ments.130 
3. Expense, Time, and Burden 
The introduction of EHR systems into medical practice can in-
volve significant costs and difficulties. The purchase of an EHR sys-
tem is estimated to cost $33,000 per doctor, with an additional $1500 
                                                                                                                  
124. See 45 C.F.R. §§ 160.300−.552 (2007). 
125. As of December 31, 2007, HHS received 32,487 complaints of HIPAA Privacy Rule 
violations. See Privacy — Compliance and Enforcement, http://www.hhs.gov/ocr/privacy/ 
enforcement/numbersglance.html (last visited Dec. 19, 2008). However, no civil fines had 
been imposed, and only four criminal actions had been brought under HIPAA’s criminal 
enforcement provision. See Tresa Baldas, Hospitals Fear Privacy Claims Over Medical 
Records, NAT’L L.J., May 28, 2007, at 4, 4. 
126. Hoffman & Podgurski, supra note 121, at 350–54. 
127. HIPAA Compliance Strategies: National Review of HIPAA Compliance Finds Ram-
pant Confusion, Mistakes, REP. ON PATIENT PRIVACY (Atl. Info. Servs., Inc., Washington, 
D.C.), May 2007, available at http://www.aishealth.com/Compliance/Hipaa/ 
RPP_National_Review_Rampant_Mistakes.html. 
128. Hoffman & Podgurski, supra note 121, at 359–84 (developing recommendations for 
the improvement of the HIPAA Privacy and Security Rules). A recently proposed bill, the 
Health-e Information Technology Act, H.R. 6898, 110th Cong. §§ 400–15 (2008), would 
bolster privacy and security safeguards. See THE HON. PETE STARK, CHAIRMAN, H. COMM. 
ON WAYS AND MEANS, SUBCOMM. ON HEALTH, PRIVACY AND SECURITY PROVISIONS OF 
HEALTH-E IT ACT OF 2008 (Comm. Print 2008), available at http://www.house.gov/ 
stark/news/110th/legislation/200809-HIT/privacy.pdf. 
129. CARL H. COLEMAN ET AL., THE ETHICS AND REGULATION OF RESEARCH WITH 
HUMAN SUBJECTS 446–47 (2005) (discussing state medical confidentiality laws); see, e.g., 
N.Y. PUB. HEALTH LAW § 17 (McKinney 2002) (prohibiting disclosure of a minor’s medi-
cal records concerning abortion and sexually transmitted diseases without the minor’s con-
sent); 71 PA. CONS. STAT. ANN. § 1690.108 (West 1990) (prohibiting disclosure of records 
prepared during drug and alcohol abuse treatment); see also Health Privacy — State Law, 
http://www.healthprivacy.org/info-url_nocat2304/info-url_nocat_search.htm (last visited 
Dec. 19, 2008) (summarizing and providing links to the health information privacy laws of 
each state). 
130. Terry & Francis, supra note 11, at 709–10 (discussing how state laws can present 
challenges for a national EHR system); NCVHS, supra note 114, at 9 (describing the confu-
sion, difficulty, and expense of designing a national health information network to comply 
with numerous health privacy laws enacted by the states). 
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a month per doctor for maintenance.131 According to a study of Penn-
sylvania hospitals, the median capital spending per bed for HIT in 
2006 was $6912, while the median HIT operating cost per bed was 
$14,528.132 The cost of achieving a fully interoperable NHIN has been 
estimated at $156 billion in capital investment and $48 billion in year-
ly operating expenses over five years.133 
Transitioning to an EHR system can also place significant admin-
istrative burdens upon health care providers. The potential difficulties 
of EHR implementation include all of the following: (1) office sys-
tems must be redesigned; (2) users must adopt uniform ways of re-
cording data to fit system requirements and must forego their own 
shorthand and terminology; (3) data from paper records must be en-
tered into the electronic system; (4) all staff members must learn to be 
proficient with the system, and their training takes time away from 
patient care; and (5) patients may be concerned about providers 
spending considerable time inputting data into computers during ex-
aminations, leaving less time for human interaction between the clini-
cian and the individual being examined.134  
Even in the long term, use of EHR systems may be time consum-
ing for providers.135 Typing may take physicians longer than dictating 
notes.136 One study found that, during consultation, use of EHRs in-
creased the time that doctors spent on activities other than interacting 
with patients by as much as twenty-eight percent and that this did not 
change with improved computer proficiency.137 Other writers have 
noted that, in the intensive care unit, where numerous interventions 
                                                                                                                  
131. Thomas Goetz, Editorial, Physician, Upgrade Thyself, N.Y. TIMES, May 30, 2007, at 
A21; see also Baron et al., supra note 70, at 223–24 (reporting that an EHR system cost a 
four-person medical practice $140,000, including hardware, software, training, and one year 
of support, and estimating the system’s annual maintenance cost, including support services, 
to be $40,000). 
132. HOSP. & HEALTHSYSTEM ASS’N PA., IMPROVING PATIENT CARE: PENNSYLVANIA 
HOSPITALS’ USE OF INFORMATION TECHNOLOGY 4 (2007), available at 
http://www.haponline.org/downloads/Improving_Patient_Care_PA_Hospitals_Use_of_IT_
HAP_082007.pdf. Capital costs include buildings, medical equipment, and EHR systems, 
while operating costs include the daily expenses of running a hospital. Id. 
133. Rainu Kaushal et al., The Costs of a National Health Information Network, 
143 ANNALS INTERNAL MED. 165, 170 (2005). 
134. See, e.g., Baron et al., supra note 70, at 223–24 (describing the difficulties one prac-
tice faced in implementing a new EHR system); Connolly, supra note 64 (relating that Ce-
dars-Sinai Medical Center in Los Angeles abandoned its $34 million EHR system after staff 
members found that it was “clunky and slow” and that they could not operate it effectively, 
because they had received insufficient training); Terry, supra note 111 (describing difficul-
ties associated with EHR implementation). 
135. Yong Y. Han et al., Unexpected Increased Mortality After Implementation of a 
Commercially Sold Computerized Physician Order Entry System, 116 PEDIATRICS 1506, 
1510 (2005) (asserting that CPOE systems require more time for order entry than written 
forms, although this may be mitigated by improved overall efficiency). 
136. See Baron et al., supra note 70, at 223–24 (discussing increases in patient waiting 
times due to the adoption of an EHR system). 
137. Mitchell & Sullivan, supra note 62, at 281. 
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must be performed in rapid succession, CPOE systems may increase 
mortality because staff members must spend significant time at com-
puter terminals rather than at the bedside.138 How time consuming and 
problematic an EHR system is, however, depends largely upon its 
user interface design.139 Enhanced designs, including mechanisms 
such as voice recognition software, allow users to operate systems 
more quickly and more safely.140  
4. Legal Issues 
Use of EHR systems may raise important tort litigation ques-
tions.141 Addressing all of the issues in detail is beyond the scope of 
this Article, but some bear mentioning. For example, to what extent 
will a physician’s reliance on guidance provided through decision 
support mechanisms insulate her from liability? Will EHR system 
vendors be included as a matter of course in every lawsuit because the 
provider’s system might possibly have contributed to the alleged in-
jury?142 If so, will concern about litigation impede NHIN implementa-
tion, or will vendors demand immunity?143 Will frequent attempts to 
prove failures in complex EHR systems through the testimony of cost-
ly expert witnesses drive the costs of litigation and malpractice insur-
ance dramatically higher? 
Furthermore, a patient harmed by a malfunction or security vul-
nerability of an EHR system may face difficulties proving her claims. 
The patient may find it very hard to establish that the system was re-
sponsible for her injuries unless the inputs provided to the system, the 
actions taken by users, and the outputs and actions generated by the 
system are faithfully recorded in a form that can be understood by an 
expert. It can be extremely challenging to inspect a complex EHR 
system’s program code for the defect that was responsible for a failure 
                                                                                                                  
138. See, e.g., Han et al., supra note 135, at 1510. 
139. See Michael E. Wiklund, Making Medical Device Interfaces More User-Friendly, in 
DESIGNING USABILITY INTO MEDICAL PRODUCTS 151–60 (Michael E. Wiklund & Stephen 
B. Wilcox eds., 2005) (discussing user-interface problems and techniques for enhancing the 
user-friendliness of medical device interfaces). 
140. See id.; Ken Terry, Voice Recognition Moves Up a Notch: When the Computer Can 




141. See, e.g., Burton et al., supra note 43, at 465–66 (discussing the uncertainties re-
garding legal liability of physicians relying on data from other providers). 
142. See Arnold J. Rosoff, On Being a Physician in the Electronic Age: Peering into the 
Mists at Point-&-Click Medicine, 46 ST. LOUIS U. L.J. 111, 124–28 (2002) (discussing 
liability of developers of clinical decision-support software and justifiable reliance by phy-
sicians). 
143. See ROBERT WOOD JOHNSON FOUND. ET AL., supra note 22, at 45 (noting that “im-
munity from suit is extremely rare” and that it is possible that HIT will generate new 
sources of liability).  
24  Harvard Journal of Law & Technology [Vol. 22 
 
that harmed a patient. Such a defect might involve only one line of 
code among many thousands. 
Discovery issues might be particularly copious. For example, will 
printouts of EHRs accurately reflect the providers’ activities? Will 
fragmented screen displays, physician shortcuts, and system inflexi-
bilities impede discovery and distort the medical record?144 Will 
EHRs record all of the providers’ activities accurately, comprehen-
sively, and chronologically, or will files be disjointed, confusing, and 
incomplete? Will e-mail messages exchanged between patients and 
physicians be captured by the EHR system and become part of the 
medical record?145  
On the other hand, EHRs could significantly facilitate discovery 
of the truth in litigation. If all medical interventions are faithfully re-
corded in EHRs, computerized records will be much more compre-
hensive than paper files built upon dictation of physicians’ summary 
notes. EHR systems could also ease the burdens of discovery by al-
lowing for electronic searches of medical files.146 Both plaintiffs and 
defendants could use EHRs to their advantage in litigation.147  
III. THE ROLE OF THE LAW AND ADMINISTRATIVE 
REGULATION 
A. Why Are Legal Interventions Necessary? 
EHR systems are not currently regulated by any governmental en-
tity despite being crucial to the effective management of patient care 
in practices that use them.148 There are at least two important reasons 
for governmental involvement in the realm of EHR systems. First, 
EHR systems are unlikely to be widely adopted in the near future 
without governmental intervention. The government should require all 
health care providers to adopt EHR systems and offer financial sup-
port to offset the providers’ costs. Second, individual patients’ lives 
and public health will depend on the proper functioning of EHR sys-
                                                                                                                  
144. See supra notes 102–13 and accompanying text (discussing the potential for errors 
generated by EHR systems). 
145. See ROBERT WOOD JOHNSON FOUND. ET AL., supra note 22, at 45 (“To the extent 
that electronic technology makes the meaning of a medical record ambiguous, the scope of 
discovery could extend beyond the limits now imposed in paper medical record cases.”).  
146. See FED. R. CIV. P. 26(b)(2) advisory committee’s note to 2006 amendments (“Elec-
tronic storage systems often make it easier to locate and retrieve information.”). 
147. See infra Part IV.C.3 (discussing audit trails and capture/replay and their potential 
role in litigation). 
148. See Jason Miller, FDA to Propose Rule on E-Health Records, GOV’T HEALTH IT, 
June 5, 2007, http://www.govhealthit.com/online/news/102901-1.html (quoting Tim Stitely, 
the FDA’s chief information officer, as stating that the FDA does not have jurisdiction to 
regulate EHRs and that he is uncertain as to which agency will regulate them). 
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tems; therefore, like other goods and services that impact public wel-
fare, EHR systems must be regulated. 
1. Financial Support for Universal EHR System Adoption 
Although many believe that EHR systems can dramatically im-
prove the quality of health care in the U.S.,149 the majority of health 
care providers have failed to adopt EHR systems thus far. According 
to a recent national survey, as of early 2008, only 4% of U.S. physi-
cians in ambulatory care settings had fully functional EHR systems, 
and 13% had basic systems.150 A fall 2006 survey by the American 
Hospital Association concluded that 11% of hospitals had fully im-
plemented EHRs, while 57% had partially implemented EHRs.151 The 
survey also found that physicians in only 10% of hospitals routinely 
used CPOE at least half of the time.152 A 2006 study of community 
health centers showed that 26% asserted that they had some EHR ca-
pacity, and those serving largely poor and uninsured patients were 
unlikely to have any EHR capabilities.153  
Commentators have, in fact, noted a misalignment of incentives. 
While providers must invest heavily in the purchase and maintenance 
of EHR systems, it is insurers and self-insured employers who will 
reap many of the systems’ economic benefits: less frequent duplica-
tion of diagnostic tests and fewer medical errors that lead to costly 
complications.154  
One way to compel the adoption of EHR systems is to establish a 
legal mandate requiring their use by all health care providers. We rec-
ommend that federal law include such a requirement, which should be 
phased in over a period of years, with longer deadlines for smaller 
practices.155 Health care providers should be required to purchase and 
                                                                                                                  
149. See supra Part II.B (discussing the benefits of EHR systems). 
150. DesRoches et al., supra note 6, at 54. 
151. AM. HOSP. ASS’N, supra note 6, at 3, 5. Survey responses were received from over 
1,500 community hospitals, which constitute approximately one-third of all community 
hospitals in the U.S. Id. at 1. The survey also found that forty-six percent of community 
hospitals made moderate or high use of HIT, including medication order entry, test result 
review, and clinical alert mechanisms, and that fifty-one percent of hospitals used real-time 
drug interaction alerts. Id. 
152. Id. at 5. 
153. Shields et al., supra note 72, at 1376. The survey also found that “only 13 percent 
[of community health centers] have the minimum set of functionalities defined by the na-
tional HIT Adoption Initiative.” Id. 
154. See David F. Doolan & David W. Bates, Computerized Physician Order Entry Sys-
tems in Hospitals: Mandates and Incentives, 21 HEALTH AFF. 180, 183–84 (2002) (discuss-
ing lack of financial incentives for provider implementation of EHR systems); Blackford 
Middleton et al., Accelerating U.S. EHR Adoption: How to Get There from Here. Recom-
mendations Based on the 2004 ACMI Retreat, 12 J. AM. MED. INFORMATICS ASS’N 13, 14 
(2005) (discussing “misaligned incentives”). 
155. Cf. HIPAA Privacy Regulations, 45 C.F.R. §§ 164.318 & 164.534 (2007) (providing 
different compliance deadlines for various types of covered entities). 
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maintain EHR systems and also to make good faith use of their vari-
ous components, including decision support, CPOE, and other capa-
bilities. Federal regulations, consequently, should provide specific 
instructions as to what constitutes acceptable use. 
Nevertheless, we also recognize that the imposition of such a 
mandate would be unjust without financial support for those who 
must bear the expense of fulfilling it. The federal government has al-
ready recognized the problem and begun addressing it through several 
initiatives. On August 1, 2006, the Centers for Medicare & Medicaid 
Services (“CMS”) and the Office of the Inspector General adopted 
final regulations that create exceptions and safe harbors to federal 
fraud and abuse laws in order to encourage the donation of EHR sys-
tems.156 The regulations establish the conditions under which entities 
may donate interoperable EHR and electronic prescribing hardware, 
software, information technology, and training without violating the 
physician self-referral law157 and the federal anti-kickback statute.158 
The Internal Revenue Service has also recently issued a memo in 
which it established that nonprofit hospitals can provide EHR systems 
and support services to staff physicians without compromising their 
tax-exempt status.159 
In addition, several congressional bills have been designed to of-
fer various incentives to health care providers for the adoption of EHR 
systems. The proposed Wired for Health Care Quality Act of 2007 
would provide $139 million in fiscal years 2008 and 2009, as well as 
further funding in subsequent years for HIT-related grants and loans 
to health care providers and to states.160 Likewise, the Health-e Infor-
mation Technology Act of 2008 proposes incentive payments of up to 
$40,000 over five years to physicians and several million dollars to 
hospitals for HIT adoption.161 While such incentive programs may 
                                                                                                                  
156. 42 C.F.R. § 411.357(v)-(w) (2007); 42 C.F.R. § 1001.952(x)-(y) (2007); see Press 
Release, U.S. Dep’t of Health & Human Servs., New Regulations to Facilitate Adoption of 
Health Information Technology (Aug. 1, 2006), available at http://www.hhs.gov/news/ 
press/2006pres/20060801.html.  
157. See 42 U.S.C. § 1395nn (2000 & Supp. V 2005), amended by Medicare Improve-
ments for Patients and Providers Act of 2008, Pub. L. No. 110-275, 122 Stat. 2494. 
158. See 41 U.S.C. §§ 51–58 (2000). 
159. Memorandum from Lois G. Lerner, Exempt Organizations Director, Internal Reve-
nue Service, Hospitals Providing Financial Assistance to Staff Physicians Involving Elec-
tronic Health Records (May 11, 2007), available at http://www.irs.gov/pub/irs-tege/ 
ehrdirective.pdf.  
160. Wired for Health Care Quality Act, S. 1693, 110th Cong. §§ 3008(a)(1), (b)(1), 
(e)(1) (2007); see Senate HELP Committee Approves Health IT Legislation by Voice Vote, 
15 BNA’S HEALTH CARE POL’Y REP. 873 (2007) (reporting that the Senate Health, Educa-
tion, Labor, and Pensions Committee approved the proposed legislation on June 27, 2007). 
161. Health-e Information Technology Act, H.R. 6898, 110th Cong. §§ 301–302 (2008). 
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effectively encourage EHR system use, none of the proposed bills has 
passed thus far.162 
2. The Need for Quality Control 
The federal government must regulate EHR systems because their 
dependability and usability are crucial to patient welfare. A defect in 
the software of an EHR system containing hundreds or thousands of 
medical records, such as a flaw that causes inaccurate recording of 
patients’ allergies or medications, could adversely affect a very large 
number of patients. The risk is amplified by the fact that EHR system 
functionality extends well beyond simple record keeping. Through 
features such as decision support and order entry, EHR systems al-
ready significantly influence the course of patients’ treatments. More-
over, it is possible that, before long, the analytical power of these 
systems will increase so much that they will assume a key role in 
medical diagnosis and treatment management.  
The potentially devastating effect of system malfunctions is illus-
trated by the following incident. A hospital pharmacy’s computer 
program generated erroneous medication order lists, leading to the 
delivery of the wrong drugs to patients in the wards.163 Had the hospi-
tal staff not been vigilant and detected the mistakes, the consequences 
could have been catastrophic for some patients.164 
 A website entitled Bad Health Informatics Can Kill provides var-
ious examples of instances in which CPOE led to serious errors as 
well as other illustrations of how medical mistakes have been caused 
by technology, though not necessarily through EHR systems.165 In 
truth, there is no way to know how many malfunctions have actually 
occurred because EHR systems are not subject to a governmentally 
mandated adverse-event-reporting requirement, unlike FDA-regulated 
drugs and devices.166 
As noted earlier, the federal government has in fact begun to re-
gulate electronic health information in the areas of privacy and secu-
rity. HHS has enacted the HIPAA Privacy and Security Rules, under 
                                                                                                                  
162. Business Leaders, Senators Urge Action on Health IT Bill, Despite Privacy Con-
cerns, 16 BNA’S HEALTH CARE POL’Y REP. 457 (2008); Jeff Day, Legislation to Advance 
EMR Adoption Unlikely to Move Before Mid-2009, Aide Says, 16 BNA’S HEALTH CARE 
POL’Y REP. 1475 (2008) (explaining that “Congress is unlikely to take action on federal 
legislation that would pay doctors to adopt electronic medical record systems until well into 
2009” because it will need to focus instead “on the economic crisis, the wars in Afghanistan 
and Iraq, and on passing fiscal year 2009 appropriations bills.”). 
163. Cook & O’Connor, supra note 17, at 80–82 (explaining that the problem was rooted 
in a backup tape that was incomplete and corrupted). 
164. Id. 
165. EFMI-WG Assessment of Health Information Systems, Bad Health Informatics Can 
Kill, http://iig.umit.at/efmi/badinformatics.htm (last visited Dec. 19, 2008). 
166. See 21 C.F.R. § 803 (2007) (discussing FDA adverse event reporting requirements). 
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which a variety of requirements have been established for the use, 
disclosure, and protection of health information.167 If the government 
is to protect patients’ privacy through regulation of HIT, then surely it 
should also safeguard patients’ health and safety by regulating the 
quality of EHR systems. 
The federal government routinely regulates goods and services 
that impact public health and welfare. For example, the Department of 
Transportation regulates pipeline and hazardous material transport, 
railroads, motor carriers, cargo containers, highway traffic, and other 
transportation matters.168 The Federal Aviation Administration 
(“FAA”) regulates air traffic, air carriers, aircraft manufacturers, 
crewmembers, pilot schools, airports, and navigational facilities.169  
Most relevant is the FDA’s extensive regulation of drugs, devices, 
and biologics.170 The term “device” is statutorily defined in relevant 
part as: “an instrument, apparatus, implement, machine . . . which 
is . . . intended for use in the diagnosis of disease or other conditions, 
or in the cure, mitigation, treatment, or prevention of disease.”171 Giv-
en that they feature decision support, order entry, and other care de-
livery and management functions, one might reasonably conclude that 
EHR systems are as essential to patient care as are many regulated 
devices.172 Furthermore, their software can be more complicated than 
that found in many computer-controlled medical devices that are sub-
ject to FDA jurisdiction.173  
Free market advocates might argue that EHR systems should re-
main unregulated because competitive market forces can safeguard 
their quality, as low-quality products will fail in the marketplace. This 
argument, however, is not persuasive for several reasons.174  
 First, government regulation is necessary to prevent market fail-
ure due to lack of information available to potential consumers. The 
                                                                                                                  
167. HIPAA Privacy Rule, 45 C.F.R. §§ 160.101–164.534 (2007); HIPAA Security Rule, 
45 C.F.R. §§ 164.302–.318 (2007); see Hoffman & Podgurski, supra note 115; Hoffman & 
Podgurski, supra note 121; supra notes 115 and 121 and accompanying text (critiquing the 
Privacy and Security Rules). 
168. See 49 C.F.R. §§ 1–1572.405 (2007) (transportation regulations). 
169. See 14 C.F.R. §§ 1–198.17 (2007) (FAA regulations). 
170. See 21 C.F.R. § 7.3(f) (2007) (defining “product” as “an article subject to the juris-
diction of the Food and Drug Administration, including any food, drug, and device intended 
for human or animal use [or] any cosmetics and biologic intended for human use”). See 
generally 21 C.F.R. §§ 1–1405.670 (2007) (food and drug regulations). 
171. 21 U.S.C. § 321(h) (2006). 
172. See INST. OF MED., supra note 2, at 5 (noting that it is important to recognize the 
many uses of EHR systems, including care delivery, management, and support processes). 
173. See Nayar & Miller, supra note 112, at 49 (discussing the complexity of EHR sys-
tems). 
174. Cf. CHARLES P. FRIEDMAN & JEREMY C. WYATT, EVALUATION METHODS IN 
BIOMEDICAL INFORMATICS 357 (2d ed. 2006) (“[W]hile having been an entirely unregulated 
market in the past, the efficacy and safety of clinical information systems are increasingly 
attracting attention, creating new challenges, opportunities, and requirements for evalua-
tion.”). 
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market cannot weed out low-quality products if consumers are not 
informed about the relative quality of the various products available. 
Without a governmentally mandated adverse event reporting require-
ment, the public may never find out which products are defective or 
inferior to others, and thus they will be unable to make educated pur-
chasing decisions. Vendors have little incentive to disclose product 
flaws to the public voluntarily. Complaints posted on Internet sites or 
blogs can be unreliable or technically imprecise and, therefore, may 
not be a trustworthy source for consumer advocacy groups interested 
in developing consumer reports. Health care providers who use EHR 
systems may hesitate to disclose adverse events suffered by patients 
that are associated with EHR systems because of the HIPAA Privacy 
Rule175 or because of fear of lawsuits by vendors. In addition, even if 
users were inclined to report system defects to publicly available 
sources, they might still be slow to recognize emergent software prob-
lems because of their subtlety or complexity, and they may fail to un-
derstand their significance.176 Consequently, absent a carefully 
regulated approval process conducted by experts, many providers 
might purchase a new EHR system before its defects were widely 
known. 
Second, market forces may be further thwarted by the fact that 
providers who have already invested in and implemented a faulty 
EHR system cannot readily take their business elsewhere. Once a pro-
vider has adopted an EHR system, it will be disinclined to switch to a 
new system, even if its current system is faulty. Such a switch could 
be prohibitively expensive and burdensome, as it would require trans-
ferring all existing patient records to a different product and training 
all staff members to adjust to the new product’s peculiarities.  
Third, while the threat of litigation might normally discourage 
sloppy software engineering, in the realm of complex HIT, liability 
might be so difficult to prove that vendors will believe they bear little 
risk of costly judgments or even of plaintiffs initiating suit.177 Plain-
tiffs’ attorneys will realize that they cannot prevail without well quali-
fied experts who invest considerable time in studying the EHR system 
at issue. Therefore, lawyers may refuse to represent all but the weal-
thiest clients who can finance the retention of such experts without 
                                                                                                                  
175. 45 C.F.R. §§ 160.101–164.534 (2007). Clinicians would need to make sure that 
whatever information they convey about incidents does not identify particular patients and 
cannot be traced to specific individuals. See id. §§ 164.502–.514 (2007) (establishing regu-
lations for the use and disclosure of protected health information). 
176. See infra notes 194–95 and accompanying text (discussing the lengthy delays that 
can precede the emergence of a problem in a complex software system). 
177. See supra Part II.C.4 (discussing proof and discovery problems); infra Part IV.C.3 
(discussing recommendations that audit trails and capture/replay be required by regulation 
to facilitate detection and proof of system failures); see also infra notes 301–02 and accom-
panying text (suggesting that the regulatory agency make adverse event reports available to 
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any certainty of recovering the costs through settlement or favorable 
judgments. 
Finally, market forces alone cannot be trusted to ensure the inter-
operability of EHR systems, which is essential to the systems’ effi-
cacy. Interoperability would likely be disfavored by vendors because 
it could reduce profits and increase costs.178 Although the earliest 
electronic hospital information systems emerged in the late 1960s,179 
interoperability has yet to be achieved, and no product has come close 
to gaining a monopoly that would eliminate the need for interoperabil-
ity among competing products.180 Furthermore, both the practice of 
customizing products to accommodate providers’ preferences and the 
inherent complexity of representing medical information constitute 
potential obstacles to interoperability.181 This important capacity will 
likely be achieved only through regulatory mandates. 
3. The Current Oversight System: CCHIT 
To its credit, the HIT industry has engaged in an effort to self-
regulate, particularly through the Certification Commission for 
Healthcare Information Technology (“CCHIT”).182 However, this 
initiative falls far short of providing comprehensive oversight for 
EHR systems. CCHIT, a private-sector organization, was created in 
2004 and is composed of three HIT industry associations: the Ameri-
can Health Information Management Association; the Healthcare In-
formation and Management Systems Society; and the National 
Alliance for Health Information Technology.183 HHS awarded CCHIT 
a three-year contract in September 2005 with a mandate to develop 
certification criteria and an inspection procedure for EHR systems in 
the areas of office-based ambulatory care, inpatient care, and interop-
erability.184 CCHIT has certified over fifty ambulatory care EHR sys-
tems and a dozen inpatient systems under its 2007 criteria.185 
                                                                                                                  
178. See infra notes 332–32 and accompanying text (discussing financial incentives 
working against the adoption of interoperable EHR systems).  
179. BIOMEDICAL INFORMATICS, supra note 1, at 451. 
180. See infra note 185 and accompanying text (discussing the numerous EHR products 
certified for use by providers). In the word-processing area, Microsoft’s Word has nearly 
achieved such a monopoly. 
181. See infra notes 327–27 and accompanying text. 
182. CCHIT: Certification Commission for Healthcare Information Technology, 
http://www.cchit.org/about/ index.asp (last visited Dec. 19, 2008). 
183. FAQ Frequently Asked Questions — CCHIT Certification Commission for Health-
care Information Technology, http://www.cchit.org/about/faq/ 
general.asp#founding (last visited Dec. 19, 2008).  
184. CCHIT, CERTIFICATION HANDBOOK 60 (2008) [hereinafter CERTIFICATION 
HANDBOOK], available at http://www.cchit.org/files/certification/08/Forms/ 
CCHITCertified08Handbook.pdf. 
185. See CCHIT, CCHIT Certified Ambulatory EHR 2007, http://www.cchit.org/choose/ 
ambulatory/2007/index.asp (last visited Dec. 19, 2008); CCHIT Certified Inpatient EHR 
2007, http://www.cchit.org/choose/inpatient/2007/index.asp (last visited Dec. 19, 2008). 
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Applicants must pay CCHIT for certification,186 and ambulatory care 
products are certified for a period of two years,187 during which 
CCHIT monitors product changes188 and requires recertification for 
products that have been significantly modified.189 
CCHIT, however, is an industry-run organization, and its certifi-
cation criteria are vulnerable to criticism as being excessively favor-
able to vendors. There are several areas of concern. First, prior to 
product testing, applicants are able to access the criteria, testing sce-
narios, and test scripts on CCHIT’s website.190 Vendors, therefore, 
need not be prepared for unanticipated tests that might reveal flaws in 
the system that they did not encounter in practicing the testing scenar-
ios. Second, all testing for clinical functionality, interoperability, and 
security occurs during one day.191 Consequently, inspectors do not 
observe the system operating over time and in a variety of usage envi-
ronments. Third, the certification jury is composed of “three clinical 
experts, at least one of whom must be a practicing physician.”192 
However, jurors cannot confer or deliberate during the demonstration 
or voting process,193 so they cannot draw each others’ attention to 
concerns or product shortcomings.  
CCHIT’s single day of testing is particularly troubling because 
experience indicates that it is unlikely to detect many significant reli-
ability and safety problems. Though there are many examples, a series 
of incidents involving the Therac-25 radiation therapy machine viv-
idly illustrates this point.. Between 1985 and 1987 six patients died of 
massive radiation overdoses caused by software defects.194 The ma-
chine had passed safety analysis in 1983, which did not include soft-
ware testing, and it was not recalled until after the sixth incident in 
1987.195 Likewise, flaws in EHR systems may not be initially obvious 
but could cause life-threatening errors after a period of time. Such 
errors could include deleting or incorrectly recording information 
about patient allergies, lists of medications already prescribed to a 
patient, or electronic medication orders. Patients who receive incor-
                                                                                                                  
186. See CERTIFICATION HANDBOOK, supra note 184, at 66–67. 
187. Id. at 45 (“The term for Ambulatory EHR Certification, as it relates to a specific 
product version, will be two (2) years from the Certification Date . . . .”). 
188. See id. at 44 (detailing penalties for discrepancies between the certified product and 
the product that a company is actually marketing). 
189. See id. at 47–49 (describing CCHIT policies and procedures pertaining to product 
modifications).  
190. Id. at 15 (urging applicants to prepare for their inspection date by reviewing the ma-
terial carefully and practicing their demonstration of the test scripts). 
191. See id. at 25–27 (describing durations of testing procedures). 
192. Id. at 28. 
193. Id. at 29.  
194. Nancy G. Leveson, & Clark S. Turner, An Investigation of the Therac-25 Accidents, 
26 IEEE COMPUTER 18, 21 (1993). 
195. Id. at 20–21. 
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rect medications or drug dosages may well suffer serious or fatal 
harm.  
CCHIT published final 2008 criteria for ambulatory care EHR 
products.196 These documents are substantial and cover many impor-
tant areas. However, they also leave significant gaps. For example, 
they do not specify requirements concerning the reliability197 or 
safety198 of EHR systems.199  
CCHIT, in fact, recognizes some of its own limitations. Its Certi-
fication Handbook states: 
[O]ur criteria at this point can only represent broad, 
basic capabilities, and . . . these may prove insuffi-
cient for some practice specialties, or may be inap-
propriate or excessive for others; . . . our criteria do 
not assess product usability, implementation service, 
product maintenance, technical and application sup-
port; and other facts.200  
Admittedly, EHR systems could be required to have almost endless 
capabilities. Determination of which capabilities should be required 
will necessitate careful deliberation and input from many interested 
parties, including physicians, patient representatives, public interest 
groups, and academic researchers.  
B. Who Should Regulate? 
If EHR systems are to be regulated, their regulation must be as-
signed to a particular agency. This Section considers several options. 
While the FDA might initially seem to be the appropriate regulatory 
agency, it is not the optimal choice, for reasons elaborated below. The 
Centers for Medicare & Medicaid Services (“CMS”) would be a bet-
                                                                                                                  
196.  CCHIT, AMBULATORY CERTIFICATION CRITERIA — FINAL CRITERIA (2008), 
http://www.cchit.org/certify/ambulatory/index.asp. 
197. The reliability of a system is the probability that it will correctly deliver services 
over a given interval of use. IAN SOMMERVILLE, SOFTWARE ENGINEERING 48 (8th ed. 
2007).  
198. A system’s safety is “a judgment of how likely it is that the system will cause dam-
age to people or its environment.” Id. 
199  This is true despite the fact that Section 5.6 of the CCHIT 2008 Certification Handbook 
indicates that the following is an approved description of the CCHIT certification program: 
The Certification Commission for Healthcare Information Technology’s 
(CCHIT®)” inspection process is based on real-life medical scenarios designed 
to test products rigorously against the clinical documentation needs of providers 
and the quality and safety needs of healthcare consumers and payers. 
CCHIT, supra note 196. 
200. CERTIFICATION HANDBOOK, supra note 184, at 40. 
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ter alternative, as would a newly created agency tasked with oversight 
of health information technology in the U.S. 
1. FDA Jurisdiction 
As noted above, the FDA thus far has not taken the initiative to 
regulate EHR systems.201 The FDA’s authority to regulate devices 
extends to computer software that is “integral to . . . or closely con-
nected with” any apparatus that delivers patient care, such as a CAT 
scanner or a respirator.202 However, its authority to regulate EHR sys-
tems is much more dubious.  
In 1989 draft guidance, the FDA declined to extend its regulatory 
authority to software that is “intended for use only in traditional ‘li-
brary’ functions, such as storage, retrieval, and dissemination of med-
ical information — functions traditionally carried out through 
textbooks or journals.”203 The FDA also exempted software with 
“general accounting or communication” and educational functions.204 
Of particular significance is the draft policy’s exemption of computer 
products, such as decision support systems, that involve “competent 
human intervention before any impact on human health occurs.”205 
EHR systems serve library, accounting, and communication functions. 
Furthermore, unlike pacemakers or respirators that operate independ-
ently once they are connected to the body, EHR systems have no im-
pact without human input and intervention. Consequently, they would 
appear to be excluded from active FDA regulation under this policy.  
In a 1996 workshop, the FDA recognized the difficulties of de-
termining what constitutes “competent human intervention,” which in 
turn determines whether medical software should be regulated by the 
agency.206 With respect to decision support, “competent human inter-
vention” requires that users have the time, motivation, and ability to 
reflect upon and challenge computer-generated data and recommenda-
tions, which may not be true in the midst of surgery or in the intensive 
care unit.207 In addition, medical software is often so complicated that 
                                                                                                                  
201. See Miller, supra note 148. 
202. See Rosoff, supra note 142, at 121. 
203. CTR. FOR DEVICES & RADIOLOGICAL HEALTH, FDA, FDA POLICY FOR THE 
REGULATION OF COMPUTER PRODUCTS 1 (proposed 1989) [hereinafter 1989 DRAFT FDA 
POLICY], available at http://www.fda.gov/cdrh/ode/351.pdf. The policy was never formally 
adopted, but the draft policy informed the FDA’s approach to stand-alone software systems 
throughout the 1990s. See Randolph A. Miller & Reed M. Gardner, Recommendations for 
Responsible Monitoring and Regulation of Clinical Software Systems, 4 J. AM. MED. 
INFORMATICS ASS’N 442, 445–46 (1997). 
204. 1989 DRAFT FDA POLICY, supra note 203, at 1. 
205. Id. at 3. 
206. FDA & Nat’l Library Med., Software Policy Workshop (Sept. 3–4, 1996) (unpub-
lished workshop handouts), available at http://www.netreach.net/~wmanning/ 
fdaswsem.htm#background.  
207. Id. 
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users cannot analyze or understand its computations and, therefore, 
cannot exercise competent human intervention.208 EHR system com-
plexity, in fact, is likely to increase as more sophisticated functions, 
such as diagnostic algorithms based on machine learning,209 are in-
corporated. Doctors who rely excessively on computer-generated di-
agnoses and treatment recommendations may fail to perceive that the 
algorithms did not account for certain conditions that are pertinent to 
their patients. By the same token, some doctors may unreasonably 
mistrust EHR system decision support, choosing to follow their intui-
tion, rather than computerized recommendations, to the detriment of 
their patients. Consequently, “competent human intervention” cannot 
protect adequately against potentially harmful software defects, since 
most clinicians will not be able to determine whether these sophisti-
cated tools have formulated the correct approach in a particular in-
stance. The 1996 workshop called for reexamination of the FDA’s 
criteria for regulatory exemptions relating to software,210 an initiative 
that has not been pursued to date. 
One option for regulating EHR systems is to include them explic-
itly within the FDA’s jurisdiction. The FDA might effect such an ex-
tension of its jurisdiction by explicitly adopting an interpretive rule 
that reconstrues its statutory authority over devices to include EHR 
systems. However, the courts have resisted past efforts by the FDA to 
expand its authority to cover an area that it has not traditionally regu-
lated. For example, in FDA v. Brown & Williamson Tobacco Corp., 
the Supreme Court concluded that the Food, Drug, and Cosmetic Act 
(“FDCA”) did not grant the FDA jurisdiction over tobacco prod-
ucts.211 When it comes to EHR systems, the HIT industry, like the 
tobacco industry, could oppose FDA regulatory authority and turn to 
the courts for relief. Consequently, the extension of the FDA’s author-
ity to EHR systems may require a revision of the FDCA’s definition 
of “device”212 to make clear that EHR systems are covered. Statutory 
amendments, however, are often hindered by special interest lobbying 
and political, rather than public policy, concerns.213  
                                                                                                                  
208. Id. 
209. “Machine learning” refers to a machine’s ability to learn to perform tasks through 
examples or analogies to similar, previously-executed tasks and to improve performance 
based on past experience. Jaime G. Carbonell et al., An Overview of Machine Learning, in 
MACHINE LEARNING: AN ARTIFICIAL INTELLIGENCE APPROACH 4 (Ryszard S. Cichalski et 
al. eds., 1985); TOM M. MITCHELL, MACHINE LEARNING 1 (1997). 
210. FDA & Nat’l Library Med., supra note 206. 
211. 529 U.S. 120, 159–60 (2000). 
212. For the current definition, see 21 U.S.C.A. § 321(h) (West 1999 & Supp. 2008). 
213. See ANTONIN SCALIA, A MATTER OF INTERPRETATION 34–35 (1997) (discussing the 
role of lobbyists and arguing that, because of their involvement, legislative history is not an 
appropriate tool for statutory interpretation); Joseph Tussman & Jacobus tenBroek, The 
Equal Protection of the Laws, 37 CAL. L. REV. 341, 350 (1949) (“Everything that emerges 
from the legislative forum is tainted by its journey through the lobby.”). 
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Even if the FDA had jurisdiction over EHR systems, regulation 
by this agency may not be the optimal approach. The regulatory 
framework that the FDA is likely to apply to EHR systems would be 
inadequate for these patient management tools.  
The FDA classifies devices into three categories based on the lev-
el of oversight deemed necessary to assure their safety and efficacy.214 
“Class I devices” do not sustain, support, or protect human life or 
health and do not present an unreasonable risk of human illness or 
injury.215 These devices are subject only to the FDA’s “general con-
trols,” such as those relating to misbranding or adulteration.216 “Class 
II devices” are used to support or sustain human life but do not pose 
the highest risk of injury. Such devices are subject to additional “spe-
cial controls” at the discretion of the Secretary of HHS.217 “Class III 
devices” sustain, support, or protect human life or health or present an 
unreasonable risk of causing human illness or injury.218 Class III de-
vices are subject to all of the above controls as well as to premarket 
approval (“PMA”) by the FDA.219 
The FDA, however, allows manufacturers to avoid the PMA 
process by showing that their new device is “substantially equiva-
lent”220 to a legally marketed predicate device.221 In order to obtain a 
finding of substantial equivalence, applicants can submit what is 
known as a “510(k) application.”222 The FDA will grant a PMA ex-
emption if it determines that the device at issue has the same intended 
use as the predicate device and the same technological characteristics 
or that the device is demonstrably as safe and effective as an already 
marketed device.223 Furthermore, the HHS Secretary is statutorily 
required to design information requests so that they are minimally 
                                                                                                                  
214. 21 U.S.C.A. § 360c (West 1999 & Supp. 2008); see A PRACTICAL GUIDE TO FOOD 
AND DRUG LAW AND REGULATION 127–30 (Kenneth R. Piña & Wayne L. Pines eds., 2d ed. 
2002) [hereinafter A PRACTICAL GUIDE]. 
215. 21 U.S.C.A. § 360c(a)(1)(A). 
216. A PRACTICAL GUIDE, supra note 214, at 128. 
217. 21 U.S.C.A. § 360c(a)(1)(B). 
218. Id. § 360c(a)(1)(C). 
219. Id. 
220. Id. § 360c(i). 
221. Id. § 360c(f)(1); Benjamin A. Goldberger, The Evolution of Substantial Equivalence 
in FDA’s Premarket Review of Medical Devices, 56 FOOD & DRUG L.J. 317, 318, 325–27 
(2001) (discussing substantial equivalence). 
222. Goldberger, supra note 221, at 318. The 510(k) application is named after the 
FDCA section that originally authorized the process, now codified at 21 U.S.C. 
§ 360c(f)(1)(A). Eric Chan, Comment, The Food and Drug Administration and the Future 
of the Brain-Computer Interface: Adapting FDA Device Law to the Challenges of Human-
Machine Enhancement, 25 J. MARSHALL J. COMPUTER & INFO. L. 117, 142 n.152 (2007). 
223. 21 U.S.C.A. §§ 360c(f)(1), 360c(i)(1)(A). 
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burdensome to 510(k) applicants.224 Accordingly, the FDA requires 
clinical data for only a minority of 510(k) reviews.225 
The 510(k) process has become so popular with manufacturers 
who wish to avoid the more onerous and lengthy PMA procedure that 
over seventy-five percent of medical devices are approved through 
this process.226 The 2004 Center for Devices and Radiological Health 
(“CDRH”) annual report shows a consistent ten-to-one ratio of ap-
proved 510(k) applications to approved PMA applications from fiscal 
years 1999 through 2004.227 Moreover, according to one source that 
reviewed 510(k) applications in the early 1990s, CDRH generally 
rejected only two percent of the applications.228 
In light of this approval framework, it is unlikely that EHR sys-
tems would receive adequate scrutiny by the FDA. First, because 
EHR systems do not directly sustain, support, or protect human life or 
health, they may well be deemed Class I devices, which receive mi-
nimal oversight. Second, even if they are categorized as Class III de-
vices, after the FDA approves the first EHR system, subsequent 
systems would probably be reviewed under the substantial equiva-
lence standard rather than the more rigorous PMA standard.229 Two 
EHR systems produced by different vendors, however, are likely to 
have very different programming, and hence their reliability may dif-
fer dramatically. Thus, the 510(k) process is ill-suited to the approval 
of new EHR systems and should not be the basis of EHR system regu-
lation.  
Finally, the FDA is currently a beleaguered entity. The FDA is 
subject to budgetary limitations that could constrain its ability to exer-
cise adequate oversight over complicated technological devices.230 
The agency has also been heavily criticized for inadequacies in its 
approval and monitoring processes and for other shortcomings.231  
                                                                                                                  
224. Id. § 360c(i)(1)(D) (“[T]he Secretary shall consider the least burdensome means of 
demonstrating substantial equivalence and request information accordingly.”). 
225. Goldberger, supra note 221, at 329–30. 
226. A PRACTICAL GUIDE, supra note 214, at 134. 
227. CTR. FOR DEVICES & RADIOLOGICAL HEALTH, FDA, CDRH FISCAL YEAR 2004 
ANNUAL REPORT 28 tbl.2 (2005), available at http://www.fda.gov/cdrh/annual/ 
fy2004/fy2004.pdf (reporting that, in 2004, the CDRH approved 3,917 new 510(k)s and 39 
original PMAs). 
228. STAFF OF SUBCOMM. ON OVERSIGHT & INVESTIGATION OF THE H. COMM. ON 
ENERGY & COMMERCE, 103D CONG., LESS THAN THE SUM OF ITS PARTS: REFORMS 
NEEDED IN THE ORGANIZATION, MANAGEMENT, AND RESOURCES OF THE FDA’S CENTER 
FOR DEVICES AND RADIOLOGICAL HEALTH 38 (Comm. Print 1993). 
229. See A PRACTICAL GUIDE, supra note 214, at 140–41 (comparing the 510(k) and 
PMA procedures). 
230. Miller & Gardner, supra note 203, at 453. 
231. See, e.g., Russell Korobkin, Who Should Protect the Public? The Supreme Court 
and Medical Device Regulation, 357 NEW ENG. J. MED. 1680, 1680 (2007) (“[T]he FDA’s 
post-approval monitoring system has been widely considered to be underfunded and ham-
strung by the agency’s limited authority.”); Bruce M. Psaty & R. Alta Charo, FDA Re-
sponds to Institute of Medicine Drug Safety Recommendations — In Part, 297 JAMA 1917, 
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2. Oversight by the Center for Medicare & Medicaid Services or a 
Newly Created Agency 
The existing agency that might be best suited to regulate EHR 
systems is the Center for Medicare & Medicaid Services (“CMS”). 
According to CMS, as of 2002, 79.3 million individuals were CMS 
beneficiaries through Medicare, Medicaid, and the State Children’s 
Health Insurance Program (“SCHIP”),232 and providers earned ap-
proximately thirty-three percent of their revenues from the public pro-
grams overseen by CMS.233 Essentially all hospitals and the 
overwhelming majority of physicians in the U.S. participate in Medi-
care, and many participate in Medicaid. Thus, they must follow CMS 
mandates.234 CMS has broad regulatory authority and has promul-
gated numerous federal regulations.235 Consequently, assigning EHR 
system oversight to CMS would not subject most providers to regula-
tion by an unfamiliar agency; rather, it would add to the requirements 
they must already meet in order to achieve CMS compliance. Fur-
thermore, if enforcement provisions include the threat that violators 
would be denied Medicare, SCHIP, or Medicaid reimbursement, 
compliance is likely to be high.236  
In order to extend CMS jurisdiction to the minority of providers 
that do not participate in any federal health care program, Congress 
would need to pass enabling legislation that would provide the agency 
with authority to regulate all EHR systems with respect to all patients, 
                                                                                                                  
1917–19 (2007) (noting that the FDA is underfunded even though the products it regulates 
constitute 25% of the U.S. gross domestic product, that it suffers from a lack of transpar-
ency, that the agency relies on a “postmarketing surveillance system that could hardly be 
weaker,” and that its post-approval enforcement mechanisms are often limited to threats of 
bad publicity); Sheila Weiss Smith, Sidelining Safety — The FDA’s Inadequate Response to 
the IOM, 357 NEW ENG. J. MED. 960, 961 (2007) (“[T]he very structure of the FDA margin-
alizes safety.”); Andrew Pollack, New Sense of Caution at F.D.A., N.Y. TIMES, Sept. 29, 
2006, at C1 (discussing the “barrage of criticism” aimed at the FDA). 
232. CTRS. FOR MEDICARE & MEDICAID SERVS., PROGRAM INFORMATION ON 
MEDICARE, MEDICAID, SCHIP AND OTHER PROGRAMS OF THE CENTERS FOR MEDICARE & 
MEDICAID SERVICES: CMS PROGRAM OPERATIONS 3 (2002), http://www.cms.hhs.gov/ 
TheChartSeries/downloads/sec2_z.zip. 
233. CTRS. FOR MEDICARE & MEDICAID SERVS., PROGRAM INFORMATION ON 
MEDICARE, MEDICAID, SCHIP, AND OTHER PROGRAMS OF THE CENTERS FOR MEDICARE 
AND MEDICAID SERVICES: U.S. HEALTH CARE SYSTEM 6 (2002), http://www.cms.hhs.gov/ 
TheChartSeries/downloads/sec1_z.zip.  
234. Timothy Stoltzfus Jost, Racial and Ethnic Disparities in Medicare: What the De-
partment of Health and Human Services and the Centers for Medicare and Medicaid Ser-
vices Can, and Should, Do, 9 DEPAUL J. HEALTH CARE L. 667, 669 (2005) (describing 
Medicare participation); Sidney D. Watson, Health Care in the Inner City: Asking the Right 
Question, 71 N.C. L. REV. 1647, 1667 (1993) (stating that most hospitals participate in Me-
dicaid). 
235. See, e.g., 42 C.F.R. pts. 400-413. (2007). 
236. The HHS Secretary has authority to deny payment to skilled nursing facilities that 
have not met particular requirements. 42 U.S.C. § 1395i-3(h)(2)(B)(i) (2000). A similar 
penalty could be established for non-compliance with regulatory requirements pertaining to 
EHR Systems. 
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regardless of their Medicare, Medicaid, or SCHIP status. This ap-
proach would not be unprecedented, because CMS already enforces 
the HIPAA Security Rule,237 which governs the security of electronic 
health information for a broad range of providers, regardless of 
whether they participate in Medicare, Medicaid, or SCHIP.238 Fur-
thermore, through its enforcement of the Security Rule, CMS has ac-
quired expertise with respect to HIT.239 Nevertheless, assigning CMS 
oversight responsibilities for EHR systems would require increases in 
the agency’s human, financial, and other resources.  
A second option, which has been suggested by HHS, is to create 
an entirely new regulatory agency that will be responsible for the de-
velopment, implementation, and regulation of EHR systems and the 
NHIN.240 Congress has periodically created new agencies to regulate 
emerging areas of law. For example, Title VII of the Civil Rights Act 
of 1964 established the Equal Employment Opportunity Commission, 
which enforces federal employment discrimination laws.241 Under the 
Occupational Safety and Health Act of 1970, the Occupational Safety 
and Health Administration was established to promote workplace 
safety,242 and the Health Care Financing Administration, now the 
Centers for Medicare & Medicaid Services, was established in 1977 to 
administer the Medicare and Medicaid programs.243 Creation of a new 
agency may encounter resistance because it could be costly and would 
constitute an expansion of government. However, an adequately 
funded agency focused exclusively on HIT, with a concentration of 
technical talent and expertise, could be an effective vehicle for regu-
lating EHR systems. 
                                                                                                                  
237. 45 C.F.R. §§ 160.302–.316 (2007). 
238. See Centers for Medicare & Medicaid Services Statement of Organization, Func-
tions, and Delegation of Authority, 68 Fed. Reg. 60,694, 60,694 (Oct. 23, 2003). 
239. The Security Rule establishes administrative, physical, and technical requirements 
to safeguard the security of electronic health records. See 45 C.F.R. §§ 160.302–.316 
(2007). CMS has authority to investigate and resolve claims of alleged Security Rule viola-
tions. 45 C.F.R. §§ 160.306, 160.308 (2007).  
240. U.S. DEP’T OF HEALTH & HUMAN SERVS., SUMMARY OF NATIONWIDE HEALTH 
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241. The Civil Rights Act, 42 U.S.C. § 2000e-4 (2000); see U.S. Equal Employment Op-
portunity Commission (EEOC), http://www.eeoc.gov. 
242. The Occupational Safety and Health Act, 29 U.S.C. §§ 651–78 (2006); see Occupa-
tional Safety and Health Administration — OSHA HOME PAGE, http://www.osha.gov.  
243. CTRS. FOR MEDICARE & MEDICAID SERVS., KEY MILESTONES IN CMS PROGRAMS 
(2006), http://www.cms.hhs.gov/History/Downloads/CMSProgramKeyMilestones.pdf. 
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IV. RECOMMENDATIONS FOR A REGULATORY FRAMEWORK 
FOR EHR SYSTEMS 
This Part develops recommendations for a regulatory framework 
to govern EHR systems. First, to achieve universal EHR system adop-
tion, the government will need to provide financial support to re-
source-poor providers. The proposed regulations also address the 
design of approval and monitoring processes for EHR systems, stan-
dardization of essential system features and capabilities, and the crea-
tion of a national databank of de-identified EHRs. These 
recommendations aim to serve as a model that will initiate a discus-
sion about the need for and potential contours of a regulatory scheme 
for HIT. They do not seek to perfect all of the details of future regula-
tory provisions. 
A. Addressing the Cost of EHR System Adoption 
1. Financial Support 
As several legislators and administrative agencies have already 
recognized, it is unreasonable to expect widespread adoption of EHR 
systems without financial support.244 The transition from paper files to 
EHR systems can be expensive, complicated, and burdensome, espe-
cially for smaller medical practices.245 Given a regulatory requirement 
that all providers adopt EHR systems, the government should offer 
financial support in the form of tax credits, incentive payments, or 
grants to facilitate compliance.246 As noted above, such inducements 
have already been suggested in several Congressional bills.247  
According to many experts, governmental investments in HIT 
will be well worth their cost.248 While the expenses of purchasing and 
implementing EHR systems will likely reduce net savings initially, 
savings are predicted to rise sharply once the systems have been fully 
implemented.249 Assuming a base year of 2004, one study anticipated 
                                                                                                                  
244. See supra notes 156–59 and accompanying text (discussing incentives for EHR sys-
tem adoption). 
245. See supra notes 131–38 and accompanying text (discussing the costs and burdens of 
EHR system implementation). 
246. See CONG. BUDGET OFFICE, supra note 80, at 27 (discussing the funding activities 
of the federal government and options for further promotion of HIT). 
247. See supra notes 160–62 and accompanying text (discussing relevant legislative pro-
posals). 
248. See, e.g., Hillestad et al., supra note 61, at 1115 (2005) (“[T]here is substantial ra-
tionale for government policy to facilitate widespread diffusion of interoperable HIT.”). 
249. See id. at 1114–15; Walker et al., supra note 80, at W5-16. 
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net national savings of $21.3 billion at year five, $59.2 billion at year 
ten, and $77.4 billion at year fifteen.250 
A program of incentive payments or grants could be administered 
by the Agency for Healthcare Research and Quality (“AHRQ”), 
which is HHS’s health research services arm.251 One of the agency’s 
functions is to serve as “a major source of funding and technical assis-
tance for health services research and research training at leading U.S. 
universities and other institutions.”252 AHRQ, therefore, has consider-
able experience in administering grant programs253 and has already 
provided funding for numerous HIT-related projects.254 
2. WorldVistA 
One approach that could alleviate funding pressures and facilitate 
development of an NHIN is widespread adoption of the VA’s VistA 
system.255 VistA is an open source product.256 However, it is written 
in a programming language, MUMPS, that is currently unfamiliar to 
most programmers,257 and it is not interoperable with other systems.258 
Furthermore, the VA does not offer assistance with installation and 
maintenance to those who adopt VistA, and therefore users must hire 
vendors for these purposes.259  
                                                                                                                  
250. FEDERICO GIROSI ET AL., RAND HEALTH, EXTRAPOLATING EVIDENCE OF HEALTH 
INFORMATION TECHNOLOGY SAVINGS AND COSTS 35–36 (2005), available at 
http://www.rand.org/pubs/monographs/2005/RAND_MG410.pdf.  
251. See What Is AHRQ?, http://www.ahrq.gov/about/whatis.htm (last visited Dec. 19, 
2008). 
252. Id. 
253. See Health Care: Funding Announcements, http://www.ahrq.gov/fund/grantix.htm 
(last visited Dec. 19, 2008) (listing grant programs administered by AHRQ).  
254. AHRQ National Resource Center for Health IT, http://healthit.ahrq.gov/portal/ 
server.pt (last visited Dec. 19, 2008) (discussing AHRQ-funded state and regional HIT 
initiatives, e-prescribing pilot projects, and other undertakings). 
255. See Goetz, supra note 131. 
256. VistA Software Alliance, Vendors & Resources, http://www.vistasoftware.org/ 
resources/index.html (last visited Dec. 19, 2008). 
257. See Posting of Ignacio Valdes to LinuxMedNews, VistA and MUMPS: Big, Ugly 
and Proud, http://www.linuxmednews.com/1130420416/index_html (Oct. 27, 2005 8:40 
EDT) (“MUMPS is also loathed by programmers . . . .”). 
258. Kupersmith et al., supra note 40, at w157–58 (describing the VA’s EHR system); 
The Last Frontier: Bringing the IT Revolution in Healthcare: Hearing Before the H. Comm. 
on Government Reform, 109th Cong. (2005), (statement of Robert M. Kolodner, M.D., 
Chief Health Informatics Officer Veterans Health Administration Department of Veterans 
Affairs), available at http://www.va.gov/OCA/testimony/hgrc/050929RK.asp (stating that 
“[w]ithout data standards, we might be able to exchange health information, as we do now 
when we copy and send paper records, but we won’t be able to use it as effectively to de-
liver safer, higher-quality care” and that “[t]rue interoperability between providers simply 
cannot be achieved without data standardization”).  
259. See VistA Software Alliance, Vendors & Resources, supra note 256 (listing VistA 
service providers); see also Goetz, supra note 131 (stating that the VA is prohibited by law 
from straying from its mission to serve veterans and, consequently, it will not assist entities 
in installing or maintaining the system). 
No. 1] Electronic Health Record Systems 41 
 
In 2002, a group of VA programmers formed WorldVistA, which 
aims to extend and modify VistA for use outside the VA system and 
to assist users in mastering, installing, and maintaining the soft-
ware.260 The group received a grant from CMS to support its work.261 
In May 2007, a WorldVistA product for ambulatory care settings, 
WorldVistA EHR VOE/ 1.0, attained certification from CCHIT262 and 
thus could be broadly adopted by physicians.263 
Critics note that WorldVistA’s staffing and billing functions are 
weak.264 In addition, WorldVistA cannot be customized as easily as 
some other commercially available systems, and some feel its graphi-
cal interface is not particularly user-friendly or appealing.265 While 
these shortcomings are significant, the cost of obtaining a license and 
support contract for WorldVistA is about ten percent of the cost of 
obtaining these items for other systems, according to one source.266 
However, the costs of installation, training, maintenance, and related 
activities may not be significantly lower. 
The jury is still out as to whether the WorldVistA system can be 
sufficiently improved to become a broadly adopted, effective, and low 
cost alternative for health care providers. This option, however, is 
certainly worth exploring. 
B. Regulating Approval and Oversight of EHR Systems 
CCHIT has promoted EHR system quality by developing certifi-
cation criteria and certifying ambulatory care and hospital EHR prod-
ucts through its testing program.267 Without CCHIT, EHR systems 
would not be subject to oversight of any kind.268 However, assigning 
certification of EHR systems exclusively to CCHIT, an industry-based 
association, is inadequate. Instead, we recommend that federal regula-
tions establish a multi-step process that will involve scrutiny by a va-
riety of parties. Regulatory requirements should apply to all parties 
who develop or modify EHR system software, install it, or integrate it 
with existing systems. Health care providers who perform these func-
                                                                                                                  
260. See Goetz, supra note 131; Welcome to the WorldVistA Homepage, 
http://worldvista.org (last visited Dec. 19, 2008); About WorldVistA, http://worldvista.org/ 
WorldVistA (last visited Dec. 19, 2008).  
261. Goetz, supra note 131. 
262. See supra Part III.A.3 for detailed discussion of CCHIT. 
263. WorldVistA EHR — CCHIT Certification Commission for Healthcare Information 
Technology, http://www.cchit.org/choose/ambulatory/2006/WorldVistA-EHR.asp (last 
visited Dec. 19, 2008). 
264. See, e.g., Goetz, supra note 131. 
265. Id. 
266. Id. 
267. See CCHIT: Certification Commission for Healthcare Information Technology, 
http://www.cchit.org/certify/index.asp (providing information about CCHIT certification). 
268. See supra notes 201–04 (explaining that the FDA does not regulate EHR systems). 
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tions themselves should be deemed vendors for legal purposes relating 
to EHR system activities ordinarily performed by vendors. 
The essential components of our recommendations are the follow-
ing: (1) field testing of all new products for a significant period of 
time; (2) use of local EHR System Oversight Committees that will in 
some ways resemble Institutional Review Boards (“IRBs”);269 (3) pre-
marketing product approval by the regulatory agency; and (4) ongo-
ing, post-marketing monitoring by the Committees and the regulating 
agency to ensure that adverse event data is collected, that vendors 
respond to users’ requests for assistance, and that system failures are 
promptly investigated and addressed so that adverse health outcomes 
are avoided or minimized. These elements are developed below. 
1. Initial Approval of New Products 
New EHR systems should not be available for use without ap-
proval by the regulatory agency. To begin the approval process, appli-
cants seeking EHR system approval would submit to the regulating 
agency270 the following items: project plans; software requirements 
and specifications; software designs; test plans; test reports; documen-
tation for users and system administrators; and related documents. 
The material should include guidelines concerning how and to what 
extent health care providers can safely customize the product, together 
with a technical justification for why the permissible customizations 
are considered safe.  
Actual testing of the system would commence with “in house” 
testing by the system developer. In addition, developers may choose 
to retain CCHIT to conduct the one-day testing program that it cur-
rently offers,271 though they would not be required to do so. CCHIT 
review might be useful because it could alert developers to problems 
that they had not detected through internal testing prior to launching 
their products for pilot testing in the field.  
Prior to approval, EHR systems would be field tested for a period 
of at least six months under varied and representative usage condi-
tions.272 Such testing is needed because the occurrence of software 
failures may be highly dependent on the local operating environment 
and patterns of usage.273 The FDA recognizes the need to test soft-
                                                                                                                  
269. See 21 C.F.R. § 56.102(g) (2007) (defining “Institutional Review Board”).  
270. See supra Part III.B for discussion of which agency should have regulatory author-
ity. 
271. See supra notes 190–95 and accompanying text (discussing the CCHIT testing pro-
gram). 
272. See Richards, supra note 20, at 27 (discussing the importance of creating “a real-
world test environment”). 
273. John Musa et al., The Operational Profile, in HANDBOOK OF SOFTWARE 
RELIABILITY AND SYSTEM RELIABILITY 167, 167 (Michael R. Lyu ed., 1996) (“A software-
based product’s reliability depends on just how a customer will use it.”). 
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ware in medical devices at the user site.274 CCHIT has also recognized 
the need for systems to be observed in the field. It requires that they 
be in operation at one or more locations for forty-five days prior to 
testing.275 This requirement, however, is not sufficiently rigorous, 
because such a limited evaluation does not account for variations in 
function usage across sites or over time. Indeed, within the first forty-
five days, users may not even become thoroughly familiar with a sys-
tem or use all of its functions.276 We recommend that systems de-
signed for hospitals be tested at a small number of medium to large 
hospitals and that systems designed for ambulatory care settings be 
tested in a larger number of provider offices.  
The regulating agency should publish site-selection and testing-
period guidelines and evaluation metrics for different types of EHR 
systems. The guidelines should be based upon sound survey method-
ology277 so as to ensure that meaningful statistical estimates of ad-
verse incident frequency, software reliability,278 and other relevant 
measures are obtained. 
2. The Role of Local System Oversight Committees 
Effective approval and monitoring of all EHR systems in the U.S. 
could not be accomplished solely by the regulatory agency. Rather, it 
will have to be led by local entities that are sufficiently resourced to 
achieve thorough and constant oversight. We will call these entities 
EHR System Oversight Committees (“SOCs”), and we contemplate 
that they will be similar in some ways to IRBs.279 The use of SOCs for 
oversight of clinical software systems of various kinds was proposed a 
decade ago in an article written by two medical informatics experts, 
                                                                                                                  
274. FDA, GENERAL PRINCIPLES OF SOFTWARE VALIDATION; FINAL GUIDANCE FOR 
INDUSTRY AND FDA STAFF 27 (2002), available at http://www.fda.gov/cdrh/comp/ 
guidance/938.pdf. 
275. CERTIFICATION HANDBOOK, supra note 184, at 45 (requiring that products be in 
production use for forty-five calendar days in at least one location).  
276. See Linda M. Culp et al., Phased Implementation, in IMPLEMENTING AN EHR 
SYSTEM, supra note 20, at 111, 111 (discussing the importance of spreading “the users’ 
learning over time” and “producing several manageable peaks in cognitive load”). 
277. See generally RISTO LEHTONEN & ERKKI PAHKINEN, PRACTICAL METHODS FOR 
DESIGN AND ANALYSIS OF COMPLEX SURVEYS (2004). 
278. See SOMMERVILLE, supra note 197, at 208–09, 801 (explaining that reliability met-
rics are used to specify software reliability, that is, the system’s ability to “deliver services 
as specified”). 
279. See Sharona Hoffman, Regulating Clinical Research: Informed Consent, Privacy, 
and IRBs, 31 CAP. U. L. REV. 71, 76–78 (2003) (discussing IRBs and their functioning). 
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Randolph Miller and Reed Gardner,280 and several of our recommen-
dations overlap with theirs.281  
Hospitals and physician networks with sufficient IT resources 
would have their own SOCs. Local SOCs would also be created to 
serve resource-poor hospitals or individual providers’ offices that 
wish to join together for SOC purposes.282 Just as federal regulations 
govern the composition of IRBs,283 regulations would specify guide-
lines for the number, expertise, and diversity of SOC members.  
Vendors would need to convince provider facilities to agree to 
field test new EHR systems. Participating providers would have to 
enter existing patient records into the EHR system that is to be tested, 
which can be an onerous task; therefore, vendors would likely find it 
necessary to offer significant incentives.284 Providers might be willing 
to serve as field testers only if they are convinced that the product is 
superior to others that have already been approved or is equivalent to 
others but is less expensive. To this end, a positive evaluation from 
CCHIT based on its one-day testing process285 might be influential. 
Furthermore, vendors could offer field testers product discounts, free 
support services, and other payments or benefits, and they could 
promise that, in the event their product is not ultimately approved by 
the regulating agency, they will provide reimbursement for expenses 
incurred in testing the system.  
SOCs would charge vendors a review fee, but this would not con-
stitute a novel or unacceptable requirement. CCHIT charges a fee,286 
as do IRBs that operate for profit and bill for protocol reviews.287 
Drug and device manufacturers seeking FDA approval have also be-
come accustomed to paying the FDA user fees pursuant to the Pre-
                                                                                                                  
280. See Miller & Gardner, supra note 203, at 450 (recommending review of clinical 
software systems by Software Oversight Committees, composed of individuals with exper-
tise in “health care informatics, clinical practice, data quality, biomedical ethics, patients’ 
perspectives, and quality improvement”). 
281. See the footnotes in this Part for references to relevant proposals in the Miller & 
Gardner article. 
282. See Miller & Gardner, supra note 203, at 450 (suggesting that small practitioners’ 
offices and hospitals could “participate in regional SOCs, or possibly request consultations 
from local SOCs at larger institutions”). 
283. 21 C.F.R. § 56.107 (2007) (discussing IRB membership). 
284. In some cases, facilities may be allowed to test EHR systems using a subset of their 
patient records rather than all of them. The regulatory agency will need to develop guide-
lines as to how many records must be included in order to obtain statistically significant 
field testing results. 
285. See supra notes 190–93 and accompanying text (discussing the CCHIT testing pro-
gram). 
286. See CERTIFICATION HANDBOOK, supra note 184, at 66 (detailing fees for CCHIT 
testing). 
287. See Sharona Hoffman & Jessica Wilen Berg, The Suitability of IRB Liability, 67 U. 
PITT. L. REV. 365, 404 (2005) (discussing for-profit IRBs).  
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scription Drug User Fee Act288 and the Medical Device User Fee and 
Modernization Act of 2002.289 Furthermore, the FDA at times relies 
on paid third party reviewers during the device approval process. In 
some circumstances, device manufacturers may request that their fa-
cility inspection be conducted by an “accredited person” rather than 
by an FDA official.290  
Despite being paid a fee by vendors, SOCs are more likely to be 
neutral than CCHIT, because most of their members would not be 
HIT industry personnel. Rather, their membership would include hos-
pital HIT staff, physicians and other health care workers, community 
members representing patients, academics, and others. These indi-
viduals are likely to prioritize the best interests of practitioners and 
patients over the interests of industry and thus to subject EHR systems 
to rigorous evaluation. 
The SOCs would oversee testing, review field testing results, and 
produce a report evaluating the EHR system upon completion of test-
ing. The EHR system vendor would then submit required documenta-
tion, including the SOC’s report, to the regulatory agency, which 
would have ultimate approval authority.291  
While this multi-step process may seem onerous, it is no more 
burdensome than the traditional FDA approval process for new drugs. 
The FDA approval process entails animal testing, human testing in 
three separate phases of clinical trials, review of safety and efficacy 
research by an FDA review team, FDA review of labeling informa-
tion, and an FDA facility inspection.292 EHR systems, which are vital 
to patient health and welfare, must similarly be subjected to rigorous 
review.293  
EHR systems that are already CCHIT-certified294 and are in use at 
the time the regulations go into effect would not need to be approved 
                                                                                                                  
288. 21 U.S.C.A. § 379h (West 1999 & Supp. 2008) (detailing fees that those submitting 
human drug applications must pay). 
289. Id. § 379j(a) (detailing fees that those submitting PMAs must pay). 
290. See id. § 360m (authorizing review by accredited persons); see also Accredited Per-
sons Inspection Program, http://www.fda.gov/cdrh/ap-inspection/ap-inspection.html (last 
visited Dec. 19, 2008) (describing the program and its operation). An “accredited person” is 
one who is certified through an accreditation program to conduct certain review functions. 
The qualifications for accredited persons are listed in 21 U.S.C.A. § 360m(b)(3). 
291. See 21 C.F.R. §§ 814.20, 814.40 (2007) (discussing items that must be included in 
submissions for pre-market approval and the FDA’s authority to approve and disapprove 
these submissions). 
292. Michelle Meadows, The FDA’s Drug Review Process: Ensuring Drugs Are Safe and 
Effective, FDA CONSUMER MAGAZINE, July/Aug. 2002, at 19, 21, available at 
http://www.fda.gov/fdac/special/testtubetopatient/drugreview.html.  
293. As technology develops, some safety-critical components of EHR system decision 
support, such as diagnostic algorithms designed to detect various cancers, may need to be 
separately evaluated. In such cases, traditional clinical trials may be appropriate, and these 
could be referred to the FDA or overseen by the agency that regulates EHR systems. 
294. See CERTIFICATION HANDBOOK, supra note 184, at 8 (noting that over 100 products 
have been certified by CCHIT). 
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by the regulating agency. It would be unrealistic and excessively dis-
ruptive to require providers to suspend use of EHR systems upon 
which they already depend in order to subject them to lengthy ap-
proval processes. If such demands were made, physicians would have 
to return temporarily to using paper records and might lose access to 
critical medical history and other information about their patients. 
Systems that are already in use would be subjected to the reporting 
and monitoring requirements outlined below,295 which should be suf-
ficient to detect any product flaws that require corrective intervention. 
3. The Need for Continued Monitoring 
The operating conditions that an EHR system encounters when it 
is broadly deployed may differ from those it encountered during field 
testing. Furthermore, the system itself may be changed by the vendor 
or by users, for example, to fix defects, add new features, or accom-
modate local preferences. Therefore, system monitoring should con-
tinue for the operational lifetime of the product.  
To facilitate timely recognition of and response to emerging prob-
lems, EHR system vendors would be required to provide several me-
chanisms by which users can report difficulties. These would include 
a feature that is incorporated into the EHR system itself, such as a 
button labeled “Report System Problem,” a vendor website through 
which problem reports can be submitted, and a dedicated e-mail ad-
dress and phone number for reporting problems.296  
EHR vendors would notify the SOCs overseeing affected facili-
ties of all problems and categorize problems in terms of severity and 
potential impact on patients and providers.297 Early in the process of 
EHR system implementation, it is likely that a large percentage of 
problems will be minor ones, resulting from users’ lack of familiarity 
with the system. Once problems are resolved, vendors would notify 
SOCs and explain the resolutions. As a safeguard against vendors 
concealing problems, users could also be encouraged to report signifi-
cant problems directly to their SOCs through SOC websites or e-
mail.298  
All SOCs, in turn, would provide the regulatory agency with 
semi-annual reports of significant EHR system problems, their resolu-
                                                                                                                  
295. See infra Part IV.B.3 and accompanying text (discussing continued monitoring of 
EHR systems). 
296. Cf. Elizabeth A. Boyer & Michael W. Soback, Production Support, in 
IMPLEMENTING AN EHR SYSTEM, supra note 20, at 95, 95 (discussing how an EHR help 
desk should operate). 
297. See id. at 96 (describing a methodology for classifying and tracking problems). 
298. See Miller & Gardner, supra note 203, at 450–51 (stating that SOCs should monitor 
user complaints and ensure that vendors provide users with a help desk and correct software 
problems); see also CERTIFICATION HANDBOOK, supra note 184, at 43 (discussing CCHIT’s 
“Purchaser Complaint Process”). 
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tions, and accounts of vendors’ failures to address serious prob-
lems.299 However, SOCs and vendors would immediately report to the 
regulating agency any serious problems that might endanger the 
health of patients so that the agency can oversee the remediation proc-
ess and, if necessary, investigate and impose appropriate penalties. 
The FDA has established similar adverse event reporting requirements 
for user facilities, importers, and manufacturers of devices.300  
The regulatory agency should post confirmed problem reports on 
its website so that consumers who are considering purchasing new 
EHR systems can evaluate them in light of all available informa-
tion.301 The reports should, however, delete trade secret information, 
confidential commercial and financial information, patient informa-
tion, and information about the identities of the users who reported the 
adverse events.302 This practice would follow the precedent estab-
lished by the FDA, which has the authority to disclose redacted ad-
verse event reports for medical devices.303  
Software vendors routinely modify their systems to repair defects 
and add new features.304 Any change to existing software, including 
EHR system software, creates the possibility of operational failures 
due to newly introduced defects.305 The FDA has indicated that 7.7% 
of medical device recalls between 1992 and 1998 were attributable to 
software failures, and among these, 79% of recalls were due to defects 
introduced by changes made after the software was initially produced 
and distributed.306  
Vendors would report proposed system modifications to the 
SOCs that field tested their products with a good faith assessment of 
their potential impact on providers and patients.307 SOCs would have 
                                                                                                                  
299. See Miller & Gardner, supra note 203, at 451 (suggesting that SOCs should report 
product problems to the FDA). 
300. 21 C.F.R. § 803.1 (2007). 
301. See Miller & Gardner, supra note 203, at 451 (recommending that the FDA “collect 
and distribute aggregated, standardized reports of system-specific and global problems”). 
302. Cf. 21 C.F.R. § 803.9 (2007) (discussing public disclosure of medical device re-
ports). 
303. 21 C.F.R. §§ 803.9, 814.44(d) (2007); see Aaron Kesselheim & Michelle Mello, 
Confidentiality Laws and Secrecy in Medical Research: Improving Public Access to Data 
on Drug Safety, 26 HEALTH AFF. 483, 489–90 (2007) (calling for regulatory and legislative 
changes that would require the FDA to expand its disclosure of safety data so that research-
ers can independently assess drug safety and efficacy).  
304. See SOMMERVILLE, supra note 197, at 488–511 (discussing software evolution). 
305. See Elizabeth Boyer et al., System Integration, in IMPLEMENTING AN EHR SYSTEM, 
supra note 20, at 89, 94 (“[M]ajor upgrades can create enough data integrity and usability 
problems to pose a serious threat to patient safety and workflow efficiency.”); Nayar & 
Miller, supra note 112, at 48 (discussing various changes that can threaten the integrity of 
EHRs). 
306. FDA, supra note 274, at 3. 
307. See CERTIFICATION HANDBOOK, supra note 184, at 47–49 (discussing how CCHIT 
addresses minor and significant product changes). EHR systems should be designed so that 
changes to the system configuration can be made only by authorized system administrators 
and not by ordinary users. This constraint should apply even to seemingly minor user-
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authority to approve minor changes but would report major changes to 
the regulatory agency, which in turn could require a new approval 
process, including field testing.308  
Vendors are not the only parties that might alter EHR systems. 
Health care providers themselves often customize the systems they 
use, for example, to accommodate their preferred workflows.309 While 
many customizations entail little risk, others, such as customizing de-
cision support rules, can impact patient welfare.310 Health care pro-
viders who wish to make configuration changes or customizations to 
EHR systems that do not conform to approved customization guide-
lines311 or that directly impact patient safety would report their pro-
posed alterations to their SOCs. The SOCs would scrutinize the 
proposals to determine their potential impact on patient care and ap-
prove or disapprove them. While both SOCs and the regulatory agen-
cy would oversee significant system changes made by vendors,312 the 
SOCs alone can oversee configuration changes and customizations 
made by health care providers.  
The need to monitor technologically sophisticated devices has 
been acknowledged by industry and government. CCHIT has recog-
nized the need for periodic recertification of products.313 Likewise, 
Congress has authorized the Secretary of HHS to order post-
marketing studies of devices whose malfunctions could lead to “seri-
ous adverse health consequences.”314 EHR systems are life-critical 
devices that demand similar attention.  
Finally, the regulatory agency could maintain a feature on its 
website by which users can post comments concerning EHR systems 
that regulators will consider for purposes of future policy setting. 
                                                                                                                  
interface changes, such as moving windows, because such changes could obscure clinically 
relevant information.  
308. See id. Changes designed to fix system bugs, however, should be deployed before 
they are approved by an SOC or the regulatory agency. 
309. See Jean A. Adams et al., Workflow Assessment and Redesign, in IMPLEMENTING AN 
EHR SYSTEM, supra note 20, at 36, 36–39 (discussing tailoring workflows for particular 
organizations). 
310. For example, alerts and reminders that appear at the wrong time during the treatment 
encounter might fail to influence care decisions and improve health outcomes. See James M. 
Walker & Stephen T. Tingley, Clinical Decision Support, in IMPLEMENTING AN EHR 
SYSTEM, supra note 20, at 67, 70 (“If the reminder can only be presented after the physician 
has decided on a course of action and recommended it to the patient, it is likely to be ig-
nored.”). 
311. See supra note 270 and accompanying text (discussing customization features and 
their approval). 
312. See Boyer et al., supra note 305, at 93–94 (advocating a “structured approach” to 
large system upgrades). 
313. CERTIFICATION HANDBOOK, supra note 184, at 3. 
314. 21 U.S.C.A. § 360l (West 1999 & 2008). 
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HHS and CMS already maintain interactive sites that allow the public 
to submit questions and feedback.315  
While the proposed regulatory scheme may appear to entail the 
creation of a large and costly government bureaucracy, this need not 
be the case. CCHIT certified fewer than sixty-five products under its 
2007 criteria.316 Thus, the number of EHR systems for which approval 
is sought at any given time is likely to be limited. In addition, if more 
stringent approval and monitoring requirements are implemented, 
vendors may be even more cautious and selective in attempting to 
introduce new products to the market. 
C. EHR System Standards and Criteria 
Regulators with specialized expertise will need to formulate the 
regulations carefully, in light of input received from various stake-
holders through the statutorily mandated notice and comment pe-
riod.317 The agency will also likely find it necessary to periodically 
augment and revise the regulations and issue interpretive guidance to 
respond to the rapid pace of technological change. In this Section, we 
highlight only a few standards and requirements that deserve special 
emphasis and explanation. 
1. Best Practices Standard 
The task of crafting clear guidance concerning health information 
technology, software engineering methodology, and computer secu-
rity practices is particularly challenging. These domains are continu-
ally changing, and thus it is very difficult to create static rules to 
govern them.318 
Consequently, we recommend the adoption of a “best practices” 
standard. Specifically, the regulations should require EHR system 
vendors and health care providers to make reasonable efforts to iden-
tify and employ best practices relating to all of the following: hazard 
and risk analysis and mitigation; software development, validation, 
                                                                                                                  
315. Submit Feedback: Centers for Medicare & Medicaid Services, 
http://questions.cms.hhs.gov/cgi-bin/cmshhs.cfg/php/enduser/ask.php (last visited Dec. 19, 
2008); United States Department of Health & Human Services, Office for Civil Rights, 
http://www.hhs.gov/ocr/contact.html (last visited Dec. 19, 2008). 
316. See CCHIT Certified Ambulatory EHR 2007, http://www.cchit.org/choose/ 
ambulatory/2007/index.asp (last visited Dec. 19, 2008); CCHIT Certified Inpatient EHR 
2007, http://www.cchit.org/choose/inpatient/ 2007/index.asp (last visited Dec. 19, 2008). 
317. See 5 U.S.C. § 553(b)−(c) (2006) (establishing notice and comment requirements for 
proposed administrative rules). Initially, regulators may need to solicit input from industry 
members who are unfamiliar with the regulatory process. To this end, regulators may want 
to take advantage of eRulemaking initiatives, which allow the public to access and comment 
upon proposed federal regulations through the Internet. See Regulations.gov, 
http://www.regulations.gov/search/about.jsp (last visited Dec. 19, 2008). 
318. See Hoffman & Podgurski, supra note 115, at 11. 
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and maintenance; security measures; and system integration and op-
eration. The practices identified should be either commonly used by 
organizations doing similar work or clearly superior to best common 
practices. The best practices standard is intended to motivate EHR 
system vendors to continually maximize the dependability of their 
products. 
Vendors and health care providers could refer to consensus guide-
lines formulated by well respected professional organizations, such as 
the International Organization for Standardization (“ISO”),319 or they 
could refer to HIT and software engineering publications. Regulators 
may choose to incorporate certain consensus guidelines by explicit 
reference in the regulations. In addition, on its website, the regulating 
agency could maintain a list of resources from which vendors and 
health care providers could draw guidance concerning best practices. 
2. Interoperability 
The federal regulations must address interoperability because it is 
essential to fully realizing the potential benefits of EHR systems for 
both clinical operations and medical research.320  
Efforts to achieve HIT interoperability have been underway for 
many years. For example, in 1987, an ad hoc standards group called 
Health Level 7 (“HL7”) was established to provide a standard for the 
exchange of information among hospital computer systems.321 Now 
HL7 has in excess of 500 organizational members and 2200 individ-
ual members, and its data messaging standard is in use at over 1500 
medical facilities.322 Yet, despite HL7 and a number of other long-
term efforts to achieve full interoperability of health information sys-
tems,323 progress has been slow.324  
                                                                                                                  
319. ISO — International Organization for Standardization, http://www.iso.org/iso/ 
home.htm (last visited Dec. 19, 2008).  
320. See supra Part II.B.1 (discussing the importance of interoperability); see also Marco 
Eichelberg et al., A Survey and Analysis of Electronic Healthcare Record Standards, 
37 ACM COMPUTING SURVS. 277, 278 (2005) (“Making EHRs interoperable will contribute 
to more effective and efficient patient care by facilitating the retrieval and processing of 
clinical information about a patient from different sites [among other benefits].”); Sebastian 
Garde et al., Towards Semantic Interoperability for Electronic Health Records: Domain 
Knowledge Governance for openEHR Archetypes, 46 METHODS INFO. MED. 332, 340–41 
(2007) (discussing the importance of interoperability). 
321. BIOMEDICAL INFORMATICS, supra note 1, at 300. 
322. Id. at 301. 
323. See Eichelberg et al., supra note 320, at 278 (discussing various standards that are 
being developed to address EHR interoperability problems). 
324. B.G.M.E. Blobel et al., Semantic Interoperability: HL7 Version 3 Compared to Ad-
vanced Architecture Standards, 45 METHODS INFO. MED. 343, 345 (2006) (acknowledging 
the lengthy evolution of HL7, characterized by a “frequent change of direction” and an 
“endless series of versions,” but expressing optimism that HL7 is a maturing standard that is 
steadily improving); see Barry Smith & Werner Ceusters, HL7 RIM: An Incoherent Stan-
dard, 124 STUD. HEALTH TECH. & INFORMATICS 133, 133–38 (2006) (“[A]fter ten years of 
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The most relevant form of interoperability for our purposes is se-
mantic interoperability, by which we mean “the ability of information 
systems to exchange information on the basis of shared, pre-
established and negotiated meanings of terms and expressions.”325 In 
the context of EHR systems, this definition implies that all or part of 
an EHR created or updated on one system can be transmitted to other 
vendors’ systems in a way that permits the receiving systems to inter-
pret and utilize the transmitted data as efficiently and effectively as 
they use their own internally created EHRs.326  
One obstacle to achieving semantic interoperability between EHR 
systems is the fact that medical terminology is complex, variable, and 
evolving. Terminology varies between medical specialties, locales, 
and health care facilities, and it also varies with clinical context.327 
For example, the abbreviation “MS” stands for “mitral stenosis” in 
cardiology, “multiple sclerosis” in neurology, “morphine sulfate” in 
anesthesia, and “magnesium sulfate” in obstetrics.328 EHR systems 
that use different medical terminologies cannot communicate effec-
tively with each other without an accurate translation between their 
terminologies.  
Another barrier to achieving semantic interoperability is the fact 
that existing EHR systems produced by different vendors employ pro-
prietary internal representations of medical information that are gen-
erally incompatible with one another.329 To address this problem, it is 
necessary for all vendors to support what we will call a “common ex-
change representation” (“CER”) for EHRs. A CER is an artificial lan-
guage for representing the information in EHRs, which has well 
defined syntax and semantics and is capable of unambiguously repre-
                                                                                                                  
effort, and considerable investment . . . , the promised benefits of interoperability remain 
elusive[.]”).  
325. Kim H. Veltman, Syntactic and Semantic Interoperability: New Approaches to 
Knowledge and the Semantic Web, 7 NEW REV. INFO. NETWORKING 159, 167 (2001). 
326. This is the type of interoperability sought by HL7, one of whose core strategies is to 
“[d]evelop coherent, extendible standards that permit structured, encoded health care infor-
mation of the type required to support patient care, to be exchanged between computer 
applications while preserving meaning.” About HL7, http://www.hl7.org/about/ 
hl7about.htm (last visited Dec. 19, 2008). Simply converting an EHR to human-readable 
text and transmitting it to another system does not constitute semantic interoperability if the 
receiving system cannot automatically distinguish the elements of the EHR, such as symp-
toms, test results, diagnoses, and drug orders, and process them appropriately.  
327. Some commentators argue that the development and maintenance of a semantically 
interoperable representation for health information needs to be coordinated internationally 
and across health disciplines, a process that has been called “domain knowledge govern-
ance.” See Garde et al., supra note 320, at 336–38. 
328. Christopher G. Chute, Medical Concept Representation, in MEDICAL INFORMATICS: 
KNOWLEDGE MANAGEMENT AND DATA MINING IN BIOMEDICINE 170 tbl.6-1 (Hsinchun 
Chen et al. eds., 2005).  
329. See, e.g., Rong Chen et al., Julius — A Template Based Supplementary Electronic 
Health Record System, BMC MED. INFORMATICS & DECISION MAKING, May 2, 2007, 
http://www.biomedcentral.com/1472-6947/7/10 (discussing attempts to combine EHR sys-
tems in three facilities in Stockholm, Sweden that encountered this problem).  
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senting the information in any EHR from a typical EHR system. 
EHRs using the CER should be readily transmittable between EHR 
systems of different vendors. The CER should make it easy for ven-
dors of EHR systems to implement a mechanism for translating accu-
rately and efficiently between the CER and the system’s internal EHR 
format.330 A CER should be based on a standardized clinical termi-
nology such as SNOMED-CT.331 
Financial disincentives constitute a further impediment to inter-
operability. Interoperability may be disfavored by providers because it 
makes it easier for patients to change doctors by allowing complete 
patient files to be shared or transferred electronically to other facili-
ties.332 Additionally, clinicians may be resistant to facilitating the 
sharing of patient data because they are sensitive to confidentiality 
issues and will worry that electronically transmitted EHRs will be 
accessed by unauthorized personnel or inadvertently distributed to 
persons with whom they should not be shared.333 At the same time, 
some providers may be concerned that other clinicians who scrutinize 
their EHRs may accuse them of malpractice.  
EHR system vendors may also find interoperability unappealing 
because it makes it easier for providers who have one EHR system to 
switch to another by enabling patient EHRs to be easily transferred 
between systems. Without interoperability, the difficulty of transfer-
ring hundreds or thousand of EHRs between different systems may 
deter providers from changing their EHR vendors. 
Although HIT has been developing over several decades, interop-
erability is an elusive goal, and the industry has seen a proliferation of 
non-interoperable products.334 Today, we are far from achieving a 
                                                                                                                  
330. See Marco Eichelberg et al., Electronic Health Record Standards — A Brief Over-
view, 2006 ITI 4TH INT’L CONF. ON INFO. & COMM. TECH., available at 
http://www.srdc.metu.edu.tr/webpage/projects/ride/publications/icict06_20060810.pdf 
(discussing EHR standards that would enable information exchange). An example of a 
proposed exchange representation for medical information is the HL7 Clinical Document 
Architecture (“CDA”). See Robert H. Dolin et al., The HL7 Clinical Document Architecture, 
8 J. AM. MED. INFORMATICS ASS’N 552, 552–69 (2001). 
331. See IHTSDO: International Health Terminology Standards Development Organisa-
tion, http://www.ihtsdo.org/ (last visited Dec. 19, 2008); see also PRESIDENT’S INFO. TECH. 
ADVISORY COMM., REVOLUTIONIZING HEALTH CARE THROUGH INFORMATION 
TECHNOLOGY 21–22 (2004), available at http://www.itrd.gov/pitac/reports/20040721_hit_ 
report.pdf (recommending that SNOMED-CT be incorporated into EHR systems).  
332. David J. Brailer, Interoperability: The Key to the Future Health Care System, 
25 HEALTH AFF. W5-19, W5-20 (2005), (noting that without interoperability a health care 
enterprise “hopes to gain comparative advantage by imposing high costs on consumer 
switchover and by exercising market leverage over small-niche players such as solo physi-
cians and community hospitals”). 
333. See 45 C.F.R. §§ 160.101–.534 (2007) (emphasizing the importance of the privacy 
and security of health information). 
334. See supra text accompanying notes 178–81 (discussing obstacles to interoperabil-
ity). 
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fully interoperable NHIN.335 According to some commentators, “the 
strategy of building the network from the bottom up by establishing 
many RHIOs throughout the country is not working.”336 Because of 
funding shortages, only a handful of RHIOs are fully operational and 
self-sustaining.337 The only mechanism that is likely to achieve true 
nationwide interoperability, other than a monopoly of the EHR mar-
ket, is a federal mandate that any EHR system that is approved for 
clinical use must support a specified CER.338  
3. Audit Trails and Capture/Replay 
Because EHR systems are extremely complex, regulators and liti-
gants might find it impossible to discern certain system malfunctions 
without audit trails or capture/replay, even if they employ knowledge-
able experts. A computer system audit trail is a “generalized recording 
of ‘who did what to whom, when, and in what sequence.’”339 It is also 
possible to design software to capture its interaction with users or with 
another system in such a way that the interaction can be replayed ex-
actly as it happened, including graphical, as opposed to only textual, 
output.340 Requiring either mechanism for EHR systems would be 
analogous to the HIPAA Security Rule’s requirement of audit controls 
for systems that process electronic health information341 and to the 
Federal Aviation Administration’s mandate that certain airplanes be 
equipped with flight data recorders.342  
Audit trails and capture/replay would enable experts to determine 
whether and why EHR system malfunctions occurred and to imple-
ment appropriate interventions. Such mechanisms could also assist 
both defendants and plaintiffs in litigation by facilitating the recon-
struction of facts. Furthermore, they could ease the burdens of discov-
ery by allowing for electronic rather than manual searches of records. 
                                                                                                                  
335. See Day, supra note 35, at 1011 (explaining that “very few systems today are inter-
operable” and that EHR exchanges will be limited to local and regional RHIOs rather than 
to an NHIN for “some time to come”). 
336. CASTRO, supra note 57, at 10. 
337. See id.; Julia Adler-Millstein et al., The State of Regional Health Information Or-
ganizations: Current Activities and Financing, 27 HEALTH AFF. w60, w63, w65–w66 (re-
porting on a survey of 138 RHIOs that found that 26% were defunct, “only twenty were 
functioning at even a modest scale, and only fifteen were doing so for a broad set of pa-
tients”). 
338. See PRESIDENT’S INFO. TECH. ADVISORY COMM., supra note 331, at 24–25 (dis-
cussing the importance of developing “a single set of data standards for the most common 
forms of clinical information”). 
339. Lawrence A. Bjork, Jr., Generalized Audit Trail Requirements and Concepts for Da-
ta Base Applications, 14 IBM SYS. J. 229, 229 (1975). 
340. John Steven et al., jRapture: A Capture/Replay Tool for Observation-Based Testing, 
2000 PROC. ACM SIGSOFT INT’L SYMP. ON SOFTWARE TESTING & ANALYSIS 158, 158 
(discussing capture/replay capabilities). 
341. 45 C.F.R. § 164.312(b) (2007). 
342. 14 C.F.R. § 121.343 (2007). 
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Because of the safety-critical nature of EHR systems, there 
should be a regulatory requirement specifying that the systems include 
an audit-trail function that details all interactions between systems and 
their users and all interactions among systems. In order to permit ef-
fective system validation and problem diagnosis and resolution, such 
audit trails ought to include all system input and output that could 
affect clinical actions or that could reflect the reliability, safety, us-
ability, and security of the system. It must be noted that the accuracy 
of audit logs may be partially compromised by errors in user input, 
such as inaccurate recording of body temperature or failure to include 
physicians’ observations concerning patient symptoms. However, in 
the future, many clinical measurements such as temperature and blood 
pressure readings could be transmitted directly from instruments to 
EHRs. 
We further recommend that all EHR system vendors be required 
to support capture/replay capability within a reasonable time after the 
enactment of the regulations, unless vendors provide compelling tech-
nical evidence that doing so would harm the utility or safety of their 
systems. A reasonable implementation period might be five years, 
which would give vendors ample time to retrofit capture/replay capa-
bility to existing systems, a task that is likely to be more difficult than 
incorporating this capability into a new design.343 Vendors, however, 
should be required to support at least textual audit trails within a much 
shorter period of time, perhaps one year. 
4. Addressing Privacy and Security Concerns 
The extraordinarily sensitive nature of personal health informa-
tion makes it essential for EHR systems to be designed and operated 
in a way that protects the privacy of patients. In previous work, we 
have critiqued the HIPAA Security Rule, which governs the security 
of electronic health information, and have made detailed recommen-
dations for enhancing and clarifying its requirements.344 However, 
even if these recommendations were adopted in EHR regulations, ad-
ditional steps would be necessary to address fully the special privacy 
and security issues raised by interoperability. Interoperability between 
EHR systems requires a CER.345 It also requires a common, standard-
                                                                                                                  
343. Retrofitting capture/replay capability into an existing system may be difficult for a 
vendor if the system’s external interfaces are excessively complex, if they are no longer well 
understood due to turnover among the vendor’s programming staff, or if the changes nega-
tively affect the efficiency of the system. Also, there is a risk that new defects could be 
inadvertently introduced into the system, so substantial additional testing is necessary. 
344. Hoffman & Podgurski, supra note 121, at 359–84 (offering a variety of recommen-
dations for revision of the HIPAA Security Rule to achieve greater data security); Hoffman 
& Podgurski, supra note 115, at 11–14 (developing recommendations and illustrating how 
they could be implemented); see also supra notes 114–28 and accompanying text.  
345. See supra notes 329–30 and accompanying text (discussing the CER). 
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ized mechanism by which a provider with a particular EHR system 
can expeditiously request and receive patient information that is 
stored on a remote EHR system, even if the two systems were devel-
oped by different vendors. This capability in turn requires standard-
ized policies and mechanisms for each of the following: identifying 
patients and providers; obtaining patients’ consent for EHR access; 
granting appropriate access authorization and privileges to providers; 
authenticating access requests; and employing cryptographic tech-
niques in order to protect the confidentiality and integrity of EHRs 
during transmission.346 
As is true for a common exchange format, standardized security 
policies and mechanisms are unlikely to be adopted by vendors and 
providers without a regulatory mandate. In order to facilitate compli-
ance and provide vendors with clear guidance, the regulatory mandate 
might incorporate, by explicit reference, some established and emerg-
ing security standards, such as the Internet Engineering Task Force’s 
Transport Layer Security (“TLS”) standard347 or its Public-Key Infra-
structure (X.509) standard.348  
The prospect of an NHIN has sounded alarms among privacy ad-
vocates. Some have suggested that individuals should have the choice 
of opting out of the NHIN system entirely or of controlling access to 
their records. For example, the regulations could require that patients 
give specific consent to disclosure of certain types of data, such as 
mental health histories.349  
In principle, we oppose this approach. A comprehensive NHIN 
and full computerization of all health records could not be achieved if 
individuals were able to opt out fully or partially. A system that in-
cluded such a choice could be chaotic, in that records would be di-
vided among paper and electronic files and physicians would be 
unable to access needed information quickly. Moreover, the option 
                                                                                                                  
346. See PRESIDENT’S INFO. TECH. ADVISORY COMM., supra note 331, at 30–34 (dis-
cussing the need for unambiguous patient identification, encryption, and authentication); 
Mike Boniface et al., Accessing Patient Records in Virtual Healthcare Organisations, 
ECHALLENGES E-2005, Oct. 20, 2005, available at 
http://eprints.ecs.soton.ac.uk/12224/01/eChallenges2005-final.pdf (discussing patient con-
sent, authentication, authorization, and access control); Dimitris Gritzalis & Costas Lambri-
noudakis, A Security Architecture for Interconnecting Health Information Systems, 73 INT’L 
J. MED. INFORMATICS 305, 308 (2004) (discussing encryption); Hiroshi Takeda et al., An 
Assessment of PKI and Networked Electronic Patient Record System: Lessons Learned from 
Real Patient Data Exchange at the Platform of OCHIS (Osaka Community Healthcare 
Information System), 73 INT’L J. MED. INFORMATICS 311–16 (2004) (describing an example 
of encryption in an EHR system). 
347. See Transport Layer Security (tls) Charter, http://www.ietf.org/html.charters/tls-
charter.html (last visited Dec. 19, 2008).  
348. See Public-Key Infrastructure (X.509) (pkix) Charter, http://www.ietf.org/ 
html.charters/pkix-charter.html (last visited Dec. 19, 2008).  
349. Terry & Francis, supra note 11, at 725–30 (proposing various approaches to incor-
porating patient choice into EHR systems, including data carve-outs and secure envelopes); 
see also NCVHS, supra note 114, at 7 (discussing “[m]ethods of individual control”). 
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could degrade medical care, because physicians, not realizing that 
patients have carved out certain information, might rely on incomplete 
medical files. The opt-out alternative could also hinder the transfer of 
medical data to additional providers when their expertise is needed on 
an emergency basis, and it could prevent hospital emergency rooms 
from obtaining information that could save patients’ lives. However, 
we leave open the possibility of allowing patients to sequester sensi-
tive information so long as adequate safeguards are implemented. 
Such safeguards might include notations in EHRs that information is 
missing, emergency access to information if patients are unable to 
provide consent, and the availability of complete medication lists for 
purposes of ascertaining drug interactions.350 
Government mandates concerning patient records that limit pa-
tient choice are not unprecedented. In Whalen v. Roe,351 the Supreme 
Court evaluated a constitutional challenge to a New York statute that 
required that the state be provided with copies of all prescriptions for 
certain drugs and that specified detailed security measures for the 
storage of that information. The Court upheld the constitutionality of 
the statute, finding that it called for a legitimate exercise of the state’s 
police power and that its mandates would not constitute an impermis-
sible invasion of privacy or violation of any Fourteenth Amendment 
right.352 Following this precedent, one might reason that government 
regulations requiring the computerization of all patient records and 
their inclusion in an NHIN would also be deemed a lawful and consti-
tutional exercise of federal executive power under the Fifth Amend-
ment.353  
5. Decision Support 
Federal regulations should require EHR systems to feature state 
of the art decision support capabilities.354 These would include 
prompts, alerts, treatment suggestions, links to medical literature, and, 
as technology develops, increasingly sophisticated diagnostic and ana-
lytical tools.355  
To the extent possible, decision support would be based on wide-
ly accepted clinical practice guidelines (“CPGs”), which are 
“[s]ystematically developed statements to assist practitioner and pa-
                                                                                                                  
350. See Letter from Simon P. Cohn, Chairman, Nat’l Comm. Vital Health Statistics, to 
Michael O. Levitt, U.S. Sec’y of Health & Human Servs. (Feb. 20, 2008), available at 
http://www.ncvhs.hhs.gov/080220lt.pdf (discussing recommendations for the NHIN and 
describing specific elements that could be left to patient control).  
351. 429 U.S. 589 (1977). 
352. Id. at 602, 606. 
353. U.S. CONST. amend. V. 
354. See supra Part II.B.2 (discussing decision support). 
355. See CPRS USER GUIDE, supra note 39 (detailing features available on the VA’s 
CPRS system). 
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tient decisions about appropriate health care for specific clinical cir-
cumstances.”356 For example, a CPG for the treatment of asthma 
could be incorporated into an EHR system as a checklist that appears 
when a physician enters information indicating that a particular pa-
tient has symptoms consistent with asthma. The feature would alert 
physicians as to tests that they should conduct, and it would supply 
treatment suggestions. CPGs have been developed by various organi-
zations, including: professional societies, such as the American Medi-
cal Association and other physician specialty boards; governmental 
entities, such as the AHRQ357 and various state programs; and health 
care payers, including health maintenance organizations and health 
insurers.358 
At this time, over 2000 CPGs have been published.359 The CPGs 
vary in quality,360 and some may be designed to suit a specific agenda, 
such as cost-cutting.361 EHR system vendors cannot be expected to 
incorporate large numbers of competing and possibly irreconcilable 
CPGs into their systems, and there is no significant consensus as to 
which CPGs are the most useful or reliable. Consequently, we rec-
ommend that the AHRQ adopt a certification program for CPGs such 
as the process proposed by Professor Arnold Rosoff.362 AHRQ would 
not be the first to endorse guidelines. The FDA recognizes a large 
number of device-specific consensus standards.363 It allows applicants 
seeking device approval to submit abbreviated 510(k) applications364 
when the “FDA has recognized a relevant consensus standard.”365 
Furthermore, the FDA will approve devices partly based on confor-
mity to recognized standards.366 AHRQ could maintain a website list-
                                                                                                                  
356. BIOMEDICAL INFORMATICS, supra note 1, at 924. 
357. See AHRQ at a Glance, http://www.ahrq.gov/about/ataglance.htm (last visited Dec. 
19, 2008). 
358. See Michelle M. Mello, Of Swords and Shields: The Role of Clinical Practice 
Guidelines in Medical Malpractice Litigation, 149 U. PA. L. REV. 645, 650 (2001). 
359. National Guideline Clearinghouse, http://www.guideline.gov/search/ 
detailedsearch.aspx (last visited Dec. 19, 2008). 
360. Carter L. Williams, Note, Evidence-Based Medicine in the Law Beyond Clinical 
Practice Guidelines: What Effect Will EBM Have on the Standard of Care?, 61 WASH. & 
LEE L. REV. 479, 491–92 (2004) (analyzing the usefulness of CPGs). 
361. Mello, supra note 358, at 651. 
362. See Arnold J. Rosoff, Evidence-Based Medicine and the Law: The Courts Confront 
Clinical Practice Guidelines, 26 J. HEALTH POL., POL’Y & L. 327, 355–65 (2001) (propos-
ing a certification program for CPGs). 
363. The FDA maintains a searchable online database of recognized consensus standards, 
which currently contains over 700 such standards. Recognized Consensus Standards, 
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfStandards/Search.CFM (last visited 
Dec. 19, 2008). 
364. See supra notes 220–24 and accompanying text (discussing 510(k) applications). 
365. U.S. FOOD & DRUG ADMIN. CTR. FOR DEVICES & RADIOLOGICAL HEALTH, THE 
NEW 510(K) PARADIGM — ALTERNATE APPROACHES TO DEMONSTRATING SUBSTANTIAL 
EQUIVALENCE IN PREMARKET NOTIFICATION — FINAL GUIDANCE 9 (1998), at 
http://www.fda.gov/cdrh/ode/parad510.pdf.  
366. Id. 
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ing certified CPGs, much as the FDA maintains a website listing its 
recognized consensus standards.367 
EHR system vendors would be expected to incorporate appropri-
ate certified CPGs into their systems, and these could be automatically 
updated as CPGs change, much as other software updates are auto-
matically downloaded. For example, an EHR system tailored for use 
in an endocrinologist’s office would base decision support on the 
most up-to-date CPGs for endocrinology, while systems designed for 
internists or emergency rooms would need to incorporate a broad 
range of CPGs.  
The regulations should require EHR system vendors to use avail-
able technology to maximize the efficacy and safety of decision sup-
port features. Some researchers have found that decision support does 
not always change provider behavior.368 Some physicians may distrust 
computerized suggestions, may not appreciate a computer telling them 
how to practice medicine, or may be too busy to consider computer-
ized recommendations carefully,369 and they may too easily erase 
prompts by hitting the escape key.370 The efficacy of decision support 
can be enhanced through mechanisms such as automatic prompts that 
do not need to be deliberately initiated, highlighting, periodic remind-
ers, and carefully selected default settings.371 As a resource for ven-
dors, the regulating agency could include on its website links to 
literature providing suggestions for maximizing the benefit of deci-
sion support mechanisms.  
6. Enforcement 
The regulations would need to include enforcement provisions in 
order to ensure compliance. Both EHR system vendors and health 
                                                                                                                  
367. See Recognized Consensus Standards, supra note 363. 
368. Amit X. Garg et al., Effects of Computerized Clinical Decision Support Systems on 
Practitioner Performance and Patient Outcomes, 293 JAMA 1223, 1231–32 (2005) (stating 
that the systems’ effects on patient outcomes are not sufficiently studied and are inconsistent 
when they are examined); Handler et al., supra note 60, at 1136 (stating that the benefit of 
decision support is unclear and often does not seem to affect clinicians’ adherence to rec-
ommended guidelines). 
369. See Usha Subramanian et al., A Controlled Trial of Including Symptom Data in 
Computer-Based Care Suggestions for Managing Patients with Chronic Heart Failure, 
6 AM. J. MED. 375, 379–80 (2003) (noting that two thirds of suggestions were disregarded). 
370. William M. Tierney et al., Can Computer-Generated Evidence-Based Care Sugges-
tions Enhance Evidence-Based Management of Asthma and Chronic Obstructive Pulmonary 
Disease? A Randomized, Controlled Trial, 40 HEALTH SERV. RES. 477, 492 (2005). When 
the escape key was disabled, provider adherence to suggestions increased significantly. 
Dexter et al., supra note 62, at 968. 
371. Dexter et al., supra note 62, at 968 (noting that displaying a banner on the screen 
that stated suggestions were available and then requiring physicians to make a deliberate 
choice to view reminders was ineffective); Garg et al., supra note 368, at 1234; McDonald 
et al., supra note 37, at 244–47 (discussing the Regenstrief system’s automatic suggestions, 
which are triggered by various types of data input). 
No. 1] Electronic Health Record Systems 59 
 
care providers must be subject to regulatory enforcement. Vendors 
would need to ensure that their products conform to regulatory stan-
dards and to comply with approval and reporting procedures.372 Pro-
viders would need to adopt approved EHR systems by a specified date 
and to use them properly in providing clinical care.  
EHR system regulation would require the formulation of an ena-
bling statute,373 and the enabling statute or the implementing regula-
tions would need to include both civil and criminal penalties.374 The 
regulatory agency should also be empowered to investigate com-
plaints of non-compliance and to initiate compliance reviews on its 
own,375 just as HHS and CMS may investigate covered entities that 
are suspected of failing to comply with the HIPAA Privacy Rule.376 If 
CMS becomes the regulatory agency, the statute and regulations could 
also provide that noncompliant health care providers will be denied 
payment for services covered by Medicare, Medicaid, and SCHIP.377 
The Joint Commission, formerly the Joint Commission on Ac-
creditation of Healthcare Organizations,378 could also contribute to 
enforcement efforts. The Joint Commission is a not-for-profit organi-
zation that accredits almost 15,000 U.S. health care organizations and 
programs according to standards that it develops.379 Once EHR sys-
tem adoption becomes mandatory, the Joint Commission could add 
standards related to EHR systems to its accreditation criteria380 in or-
der to monitor entities’ adoption and effective use of these mecha-
nisms. 
                                                                                                                  
372. See supra Part IV.B. 
373. Regulatory authority could be included in new legislation or as an amendment to ex-
isting legislation, such as HIPAA or the Public Health Service Act. See S. 1693, 110th 
Cong. (2007) (proposing to amend the Public Health Services Act to add HIT provisions). 
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for HIPAA Privacy Rule violations. See 42 U.S.C. §§ 1320d-5 to 1320d-6 (2000); 45 C.F.R. 
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Rule). 
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376. Id.; see, e.g., Jaikumar Vijayan, HIPAA Audit Riles Health IT: Medical Industry on 
Edge After Feds Examine Hospital’s Security Procedures, COMPUTERWORLD, June 18, 
2007, at 1, 1 (reporting that HHS initiated a HIPAA Security Rule audit of Piedmont Hospi-
tal in Atlanta in March 2007). 
377. See 42 U.S.C. § 1395i-3(h)(2)(B)(i) (2000) (authorizing the HHS Secretary to deny 
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Medicare and Medicaid payments for new admissions). 
378. The Joint Commission Launches New Brand Identity, 
http://www.jointcommission.org/AboutUs/brand.htm (last visited Dec. 19, 2008).  
379. Facts about the Joint Commission, http://www.jointcommission.org/AboutUs/ 
Fact_Sheets/joint_commission_facts.htm (last visited Dec. 19, 2008).  
380. See Standards Frequently Asked Questions, http://www.jointcommission.org/ 
Standards/FAQs/ (last visited Dec. 19, 2008) (elaborating the Joint Commission’s current 
standards). 
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Furthermore, the threat of product liability or medical malpractice 
litigation could deter misconduct by both EHR system vendors and 
health care providers. Plaintiffs may sue providers if they suspect that 
they suffered poor outcomes because providers failed to implement or 
properly use EHR systems, for example, by neglecting to utilize deci-
sion-support features that may have averted a medical mistake. Like-
wise, plaintiffs might name EHR system vendors as defendants if they 
believe the harm is rooted at least partly in a design flaw, and health 
care providers might bring in vendors as third party defendants if they 
believe the vendors to be partially at fault.381 Audit logs and cap-
ture/replay382 would be helpful to all parties in investigating and prov-
ing their claims concerning system failures and provider negligence or 
lack thereof. 
HHS has been accused of providing only anemic enforcement for 
the HIPAA Privacy Rule and HIPAA Security Rule.383 Whatever 
agency is charged with regulating EHR systems will need sufficient 
funding to engage in robust enforcement activities. However, because 
plaintiffs can already sue both health care providers and EHR system 
vendors through the tort system, the statute need not offer a private 
cause of action to aggrieved individuals. In 2008, the Supreme Court 
held that federal legislation pre-empts common law claims that chal-
lenge the safety or efficacy of medical devices that have received 
FDA premarket approval.384 Because software defects can manifest 
for the first time long after EHR systems are initially approved,385 
similar preemption of common law claims would be inappropriate for 
these systems. 
                                                                                                                  
381. See FED. R. CIV. P. 14 (discussing third-party practice). At the same time, EHR sys-
tem failures might be very difficult to prove because of the products’ complexities, and thus 
the threat of litigation alone might be of somewhat limited value as a deterrent to malfea-
sance by vendors. See supra note 177 and accompanying text. 
382. See supra Part IV.C.3. 
383. See Hoffman & Podgurski, supra note 121, at 356–57 (discussing HHS enforcement 
activities); see also OFFICE OF INSPECTOR GEN., U.S. DEP’T OF HEALTH & HUMAN SERVS., 
NATIONWIDE REVIEW OF THE CENTERS FOR MEDICARE & MEDICAID SERVICES HEALTH 
INSURANCE PORTABILITY AND ACCOUNTABILITY ACT OF 1996 OVERSIGHT i–ii (2008), 
available at http://oig.hhs.gov/oas/reports/region4/40705064.pdf (finding that “CMS relied 
on complaints to identify any noncompliant covered entities that it might investigate. As a 
result, CMS had no effective mechanism to ensure that covered entities were complying 
with the HIPAA Security Rule or that [electronic protected health information] was being 
adequately protected.”); Baldas, supra note 125, at 4 (stating that, according to some law-
yers, “the government is finally putting teeth into a law that has yielded more than 26,000 
complaints, but only four convictions”). 
384. Riegel v. Medtronic, Inc., 128 S.Ct. 999, 1007–11 (2008). Under Riegel, common 
law claims involving products approved through the 510(k) process are not preempted. Id. at 
1007. 
385. See supra notes 194–95 and accompanying text. 
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D. Improving Health Care Through EHR-based Research 
Commentators have noted that the contemporary medical world is 
characterized by a startling degree of uncertainty.386 According to 
some estimates, as few as twenty to twenty-five percent of treatments 
have been definitively proven effective.387 EHR systems could con-
tribute significantly to the advancement of medical knowledge by fa-
cilitating extensive research initiatives.388 
The federal regulations could provide for the creation of a vast 
database consisting of de-identified patient records from hospitals, 
providers of ambulatory care, long term health care facilities, and all 
other health care settings. Providers would be required to upload re-
cords onto the site on a periodic basis, and the database would be 
overseen and operated by the designated regulatory agency.  
Electronic records can be “sanitized” automatically to remove 
identifying information,389 but the federal regulations would need to 
define what constitutes sufficient de-identification.390 In doing so, 
they would seek to ensure that data mining techniques cannot be used 
to infer patient identities from a combination of sanitized records and 
                                                                                                                  
386. See, e.g., CROSSING THE QUALITY CHASM, supra note 68, at 145 (asserting that it 
takes 15 to 20 years to translate the discovery of a more efficacious treatment into “routine 
patient care” and that “adherence of clinical practice to the evidence is highly uneven”); 
David A. Hyman & Charles Silver, The Poor State of Health Care Quality in the U.S.: Is 
Malpractice Liability Part of the Problem or Part of the Solution?, 90 CORNELL L. REV. 
893, 952 (2005) (observing that a “great deal of uncertainty exists about the ‘best’ treatment 
for particular clinical conditions, and about the ‘best’ way to perform those treatments” and 
that the “efficacy of most medical treatments has never been proven”); see also Blue Cross 
Health Plans Recommend Institute to Study Treatments’ Effectiveness, 6 MED. RESEARCH L. 
& POL’Y 278, 278 (2007) (reporting that Blue Cross urged Congress “to establish an inde-
pendent public/private institute to fund research on the comparative effectiveness of various 
medical treatments, medications, and medical devices”). 
387. John Carey, Medical Guesswork: From Heart Surgery to Prostate Cancer, the 
Health Industry Knows Little About Which Common Treatments Really Work, 
BUSINESSWEEK, May 29, 2006, at 72, 72 (asserting that many physicians “say the portion of 
medicine that has been proven effective is still outrageously low — in the range of 20% to 
25%”). 
388. Kevin M. Fickenscher, The New Frontier of Data Mining, HEALTH MGMT. TECH., 
Oct. 2005, at 26, 26, available at http://archive.healthmgttech.com/cgi-bin/arttop.asp? 
Page=1005/1005new_frontier.htm (“With the advent of the electronic health record, new 
opportunities for uncovering patterns of care we did not know existed will come to the 
forefront of medical knowledge.”). 
389. Matt Bishop et al., How to Sanitize Data, 2004 PROC. 13TH IEEE INT’L 
WORKSHOPS ON ENABLING TECHS.: INFRASTRUCTURE FOR COLLABORATIVE ENTERS. 217, 
217, available at http://nob.cs.ucdavis.edu/~bishop/papers/2004-wetice/basicsani.pdf (ex-
plaining that when sanitization is implemented, “the raw data is presented for others to 
analyze, but the data is transformed so that sensitive items are suppressed,” as is the case 
when researchers are given patient records from which identifying information, such as 
name, address, and phone number are expunged).  
390. 45 C.F.R. § 164.514(a)–(b) (2007) (stating the HIPAA Privacy Rule’s specifications 
of what constitutes de-identified data). 
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other available data.391 Although patients should not be allowed to opt 
out of inclusion in EHR systems and the NHIN,392 they should be 
provided a choice concerning inclusion in the research database. Pa-
tients would be asked to sign a consent form at the time of their initial 
visit to a provider or admission to a health care facility indicating their 
agreement or refusal to have their de-identified EHRs entered into the 
national research database.393 With sufficient reassurance that records 
will in fact be de-identified and that their confidentiality will be pro-
tected, many patients may consent to inclusion of their records in the 
database.  
Research using this information could be conducted with few 
regulatory burdens. De-identified records do not require IRB review 
and are not subject to coverage by the HIPAA Privacy Rule.394 The 
databank would be accessible to qualified researchers who register 
with the regulatory agency and meet its criteria for approval. Agency 
review committees could scrutinize applications, and the agency could 
require applicants to prove their identities and affiliations and to pro-
vide a limited description of the planned research projects, along with 
other relevant information. Access to the databank would be granted 
for a period limited to the duration of the study. 
The scientific community is already familiar with the Coriell In-
stitute for Medical Research, which maintains one of the world’s larg-
est repositories of human cells.395 The institute has distributed over 
160,000 cell lines and over 50,000 DNA samples a year to researchers 
in sixty-two countries.396 The proposed databank would constitute a 
similar resource, containing health records rather than biological sam-
ples. 
                                                                                                                  
391. Vassilios S. Verykios et al., State-of-the-Art in Privacy Preserving Data Mining, 
33 SIGMOD REC. 50, 50–57 (2004), available at http://www.sigmod.org/record/ 
issues/0403/B1.bertion-sigmod-record2.pdf (“[S]ensitive knowledge which can be mined 
from a database by using data mining algorithms, should also be excluded, because such a 
knowledge can equally well compromise data privacy.”). 
392. See supra text accompanying note 350. 
393. Patients should also be able to withdraw consent to having new information submit-
ted to the databank. However, it might not be at all feasible to expunge existing medical 
records concerning a particular patient, because they may be in use by various researchers. 
394. The federal regulations that require IRB review cover only research on human sub-
jects and define “human subject” as “a living individual about whom an investigator . . . 
obtains (1) data through intervention or interaction with the individual, or (2) identifiable 
private information.” 45 C.F.R. § 46.102 (2007); see also 45 C.F.R. § 46.101(b)(4) (2007) 
(exempting research “involving the collection or study of existing data, documents, [or] 
records . . . if the information is recorded by the investigator in such a manner that subjects 
cannot be identified, directly or through identifiers linked to the subjects”). Likewise, the 
HIPAA Privacy Rule covers only “individually identifiable health information.” See 
45 C.F.R. § 160.103 (2007) (defining “protected health information”). 
395. See Coriell Institute for Medical Research — About Coriell, http://www.coriell.org/ 
index.php/content/view/110/234/ (last visited Dec. 19, 2008).  
396. Id. 
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The databank would enable researchers to conduct comprehen-
sive, non-experimental studies based on the actual clinical experience 
of patients and care givers.397 The importance of such research capa-
bilities has already been recognized by the federal government. In 
2007, Congress authorized the FDA to oversee the creation of a na-
tional data network, the Sentinel System. This project aims ultimately 
to make the data of 100 million Americans available for purposes of 
post-marketing drug surveillance and safety analysis. The data will be 
drawn from records from Medicare, the military, private insurance 
claims, pharmaceutical purchases, and elsewhere.398  
The research databank proposed in this Article would go much 
further than this initiative. It could potentially include the records of 
all Americans, be accessible to government and to private researchers, 
and be used to study all treatments rather than focusing only on those 
involving pharmaceutical products. Once created, this databank could 
replace all smaller-scale data collections.  
While research derived from the proposed national databank 
would not be a substitute for clinical trials, it would constitute an in-
valuable supplement to them. Researchers would be able to verify the 
success or failure of treatment protocols as they are applied to differ-
ent patient populations, based on review of millions of patient files 
covering many years.  
V. CONCLUSION 
EHR systems offer great promise for significantly improving 
health care in the U.S. and around the world. The technology could 
address many of the health care system’s shortcomings and have far-
reaching positive impacts on patient welfare. For example, HIT could 
do all of the following: decrease medical errors; enhance preventive 
care; facilitate communication between doctors and patients and 
among medical team members; reduce health disparities; and advance 
biomedical research capabilities.399 
The complexity of EHR systems, however, generates many risks 
of software and hardware failures and adverse patient outcomes. Con-
sequently, they require rigorous regulation. Some risks can stem from 
system defects and others from usability problems. Advanced EHR 
systems that will be developed in the future could improve health out-
                                                                                                                  
397. See supra notes 84–100 and accompanying text (comparing experimental and non-
experimental studies). 
398. See 21 U.S.C.A. § 355(k) (West 1999 & Supp. 2008); Barbara J. Evans, Congress’ 
New Infrastructural Model of Medical Privacy, 84 NOTRE DAME L. REV. (forthcoming Feb. 
2009) (manuscript at 2–4), available at http://papers.ssrn.com/sol3/papers.cfm? 
abstract_id=1186462. 
399. See supra Part II.B (detailing the benefits of EHR systems). 
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comes to an even greater extent, but they may also pose more serious 
risks because of increased complexity. 
Although EHR system regulation is needed, it is a challenging 
and sensitive undertaking. A tension exists between the goals of regu-
lating EHR systems comprehensively and facilitating their widespread 
and imminent adoption. The more extensive and burdensome the reg-
ulations, the more providers will resist purchasing EHR systems. We 
have attempted to craft a balanced approach that provides incentives 
for EHR system development and adoption while safeguarding patient 
welfare and deterring misconduct on the part of the software and 
health care industries. As laws and regulations are promulgated in this 
area, policy makers will need to continue to consider carefully the 
competing goals and to balance oversight with promotion of HIT. 
Innumerable details and requirements could be included in the 
federal regulations. We have not offered comprehensive suggestions 
or specific regulatory language. Rather, we outlined a regulatory 
framework and focused on what we believe to be some of the essen-
tial issues in the realm of EHR system oversight. The task of EHR 
system regulation, however, must commence at the earliest opportu-
nity. It is only with appropriate statutory and regulatory interventions 
that the full benefits of this potentially transformative medical tech-
nology can be realized. 
